Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell type enriched"	"Detected in many"	135	"Glandular cells: 2098.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0"	"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.8	0.4	12.7	1.2	0.0	0.0	32.4	3.1	3.8	0.0	2.5	0.0	1.2	0.3	1.1	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6	0.0	10.7	0.0	13.0	0.8	0.0	0.5	0.0	0.0	4.5	7.0	0.0	9.6	0.0	1.1	0.0	0.0	1.0	0.0	1.6	1.0	0.8	2098.0	0.0	0.0	4.1	0.0	15.5	0.0	9.2	0.0	0.0	2.8	0.0	0.0	2.4	0.3	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	7.4	0.0	1.0	11.5
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"kidney: 63.2;liver: 63.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 87.7;Proximal tubular cells: 319.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"T-47d: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					NA	NA		7300			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favorable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	63.2	63.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.7	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.0	0.0	0.0	1.8	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	319.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602166-8612871	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;lymphoid tissue: 22.3"	"Cell type enhanced"	"Detected in single"	10	"Alveolar cells type 2: 1.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.6"	"Group enriched"	"Detected in many"	6	"B-cells: 6.6;granulocytes: 1.6"	"Group enriched"	"Detected in some"	6	"Daudi: 49.6;U-698: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	1.3	0.1	0.1	22.3	0.1	0.4	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.9	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.2	0.1	0.5	15.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	1.8	0.1	1.1	0.5	3.9	0.1	0.1	1.7	0.2	0.2	0.1	0.6	0.3	0.1	12.2	0.1	0.7	6.6	0.7	1.6	0.7	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	41.4	0.0	0.1	0.0	1.0	0.7	0.4	0.4	0.3	0.2	4.3	0.4	0.2	0.4	6.6	0.4	0.4	1.6	0.5	0.4	0.7	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.3	0.2	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2
APOBEC4	"C1orf169, FLJ25691, MGC26594, RP1-127C7.4"	ENSG00000173627	"Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4"	Q8WW27	1	183646404-183653316	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 15.9;testis: 23.6"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 93.7;Early spermatids: 101.4;Late spermatids: 71.2"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA								"unprognostic (2.27e-1)"	"prognostic favorable (2.65e-4)"				"unprognostic (2.61e-1)"		"unprognostic (3.84e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.73e-1)"		"unprognostic (7.10e-2)"	"unprognostic (4.00e-2)"			0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.0	0.1	0.2	5.4	0.0	15.9	0.0	0.0	0.1	0.1	0.0	0.0	4.1	0.0	0.0	0.0	5.6	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	23.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	93.7	19.4	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	71.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217390-27243943	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA057266, HPA069341"	Supported		Supported	Nucleoplasm		No	No		26000	Nucleoplasm		"CAB007781: AB_562057, HPA057266: AB_2683387, HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	12.0	11.9	10.1	23.1	12.4	11.1	18.9	13.3	13.1	14.6	12.4	10.9	9.7	12.1	21.0	18.0	16.3	16.6	15.8	9.8	8.6	8.8	13.1	22.9	13.0	27.9	11.8	9.5	24.4	18.1	10.7	16.4	10.6	10.1	12.5	11.6	12.9	11.7	18.3	12.3	26.0	13.2	17.3	12.5	18.7	11.4	21.3	10.8	35.2	13.8	14.1	18.5	12.7	13.1	5.1	4.9	0.8	2.3	3.7	7.9	2.6	25.3	23.0	10.2	20.5	16.7	13.7	8.1	10.8	7.5	13.6	9.7	26.0	10.1	22.7	9.8	9.8	10.5	14.4	30.1	14.3	10.3	14.8	24.3	32.4	17.5	13.5	8.3	25.5	16.4	10.4	11.8	19.8	22.6	6.3	14.6	21.1	22.8	12.7	12.0	25.5	16.2	38.0	24.6	10.7	17.5	28.5	30.7	23.6	10.1	13.0	20.6	10.3	15.0	10.7	12.6	7.9	8.4	10.7	13.1	20.7	17.1	16.1	21.6	26.4	16.9	46.4	8.3	24.6	17.8	0.0	1.2	0.5	4.7	2.3	4.0	5.1	6.5	7.7	2.7	5.0	4.3	4.3	0.8	3.7	1.2	4.9	7.9	2.6	10.1	12.4	13.3	13.1	8.6	8.8	11.8	9.5	10.1	10.8	3.0	3.8	2.2	3.7	3.3	8.9	4.8	15.3	2.7	5.7	1.8	15.7	4.7	0.0	6.1	1.1	3.8	2.5	0.0	3.0	4.7	5.0	2.4	4.6	4.9	6.9	6.4	6.3	4.3	2.4	1.4	5.8	2.2	3.3	5.4	5.2	4.1	5.3	0.0	9.2	1.3	6.2	0.0	5.1	4.9	10.0	3.0	1.8	4.5	6.8	2.0
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991717-79009867	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Mucus-secreting cells: 134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 92.2;T-47d: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	NA		2300000	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	13.8	15.3	9.6	13.1	10.2	8.1	13.0	12.2	10.8	17.7	43.8	12.3	25.4	25.5	12.0	14.3	27.5	10.0	19.5	10.8	9.0	6.9	10.3	17.7	11.1	11.5	12.5	7.7	10.4	14.7	13.1	11.8	33.0	12.0	36.7	41.5	7.9	30.3	41.4	9.0	8.9	27.2	8.0	12.4	18.1	25.8	19.0	10.3	14.1	12.4	8.9	14.4	10.3	13.7	4.1	3.8	17.5	4.4	3.1	6.2	4.4	22.2	24.4	6.8	9.9	6.5	7.8	8.8	13.8	12.1	14.8	12.6	11.6	21.1	5.4	8.1	9.6	18.1	11.3	5.8	10.8	14.9	9.0	10.6	7.0	7.4	9.6	5.6	6.7	11.1	8.0	7.0	13.7	7.5	8.8	25.6	9.1	8.8	9.2	9.8	12.1	10.1	4.0	4.7	92.2	26.0	5.7	11.2	6.1	6.5	11.2	9.9	9.9	7.3	48.8	10.4	11.4	60.2	8.0	12.7	22.2	20.1	9.9	17.2	10.9	9.0	5.3	14.2	5.2	13.9	6.1	3.8	8.1	6.2	4.4	6.1	4.1	4.6	5.2	3.8	2.9	4.5	4.4	17.5	3.1	2.9	2.7	3.8	4.4	9.6	10.2	12.2	10.8	9.0	6.9	12.5	7.7	12.0	10.3	26.8	19.4	13.7	13.8	14.7	5.9	11.6	15.3	6.7	10.3	12.2	13.7	30.3	3.3	30.3	11.4	14.3	61.6	23.3	25.4	31.5	12.3	34.8	5.7	12.1	21.5	4.8	49.0	54.6	9.2	10.4	10.9	11.3	13.5	11.8	134.8	6.7	27.4	49.1	7.1	6.1	8.5	6.5	7.2	23.2	5.5	11.4	84.9	10.2	83.2	16.5
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Cell line enhanced"	"Detected in many"		"A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	42.9	4.2	0.0	0.0	0.0	1.3	0.0	3.3	0.9	0.8	3.4	0.2	28.6	0.0	1.6	6.8	1.8	15.1	0.8	11.2	2.2	0.0	0.8	0.0	40.6	5.4	0.3	0.0	0.0	1.9	1.8	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.0	20.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	51.0	0.0	0.0	0.5	0.0	1.2	0.7	0.0	1.7	3.9	0.2	0.0	0.0	0.0	0.5	18.0	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9	3.0	1.4	0.9	0.2	1.3	0.1	2.8	2.5	0.0	0.0	5.2	0.0	0.2	36.5	2.4	0.6	4.4	120.2	0.0	1.3	2.7	1.0	0.9	0.0	94.4	6.1	0.0	0.0	28.8	118.1	0.8	0.3	3.7	0.0	0.0	12.5	0.0	70.1	48.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.1	1.5	4.9	0.3
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		2100000	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	35.0	17.0	28.5	30.4	24.4	14.8	72.2	18.0	35.8	26.8	44.8	17.8	20.9	53.7	16.5	19.3	42.2	13.5	39.2	28.6	28.0	31.4	26.2	88.2	36.8	46.2	35.1	16.8	16.2	42.3	19.3	16.6	16.0	25.4	32.8	48.1	16.2	50.8	18.3	30.4	22.2	64.9	46.9	33.1	21.6	35.9	8.6	18.2	25.6	31.7	26.7	28.0	34.0	39.0	11.2	10.6	23.1	12.4	15.0	17.5	12.1	30.8	17.3	22.4	20.0	40.9	47.9	31.7	54.9	33.1	33.4	34.0	15.4	21.4	45.7	28.3	37.2	31.4	21.0	16.5	28.4	45.8	69.1	13.5	35.5	23.9	26.5	26.7	50.6	26.0	26.8	34.4	27.8	31.3	31.6	34.5	17.1	33.5	36.9	43.5	11.3	41.0	23.9	14.2	40.6	24.0	25.6	38.8	34.3	32.5	34.0	20.3	10.7	39.3	45.7	31.5	30.9	11.3	30.2	32.3	41.8	24.2	39.9	45.1	26.9	37.2	31.2	33.0	31.3	28.5	23.1	10.2	18.2	13.6	10.7	17.5	11.2	15.5	16.7	10.6	10.2	14.7	14.0	4.2	15.0	12.4	8.9	16.0	12.1	28.5	24.4	18.0	35.8	28.0	31.4	35.1	16.8	25.4	18.2	65.5	42.5	120.7	103.0	155.9	32.3	44.9	101.9	57.6	33.0	71.5	15.7	70.1	147.6	156.9	1.2	74.2	219.2	46.7	158.3	115.0	53.6	209.9	94.4	215.9	69.9	41.3	112.9	68.2	97.0	4.1	55.0	98.6	241.3	77.5	273.0	40.6	127.4	150.8	65.7	149.9	26.0	84.1	148.0	8.2	27.2	170.5	99.0	139.5	184.6	187.9
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979335-41012565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Approved	"Actin filaments,Cytosol"		NA	Yes			Cytosol	"Actin filaments"	"CAB017111: , HPA051322: AB_2681441"	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	7.1	10.0	4.5	10.8	7.8	9.7	5.1	5.9	9.8	14.4	23.6	5.8	16.3	4.3	25.9	8.4	11.3	21.9	13.4	6.7	4.7	5.1	8.6	26.4	7.0	9.4	7.9	4.7	10.1	6.3	16.8	5.4	7.7	6.2	14.4	9.8	9.1	56.5	19.6	13.2	5.8	13.5	35.8	5.1	7.5	9.0	11.8	6.7	14.6	4.5	11.3	13.2	21.3	9.5	6.0	12.8	0.0	7.3	6.6	7.0	3.8	21.2	19.5	27.6	22.2	7.6	9.5	43.4	37.4	16.1	41.1	27.7	38.3	18.9	39.9	17.0	17.1	11.3	15.0	29.5	27.9	41.1	16.7	22.4	24.4	26.0	12.1	25.0	32.5	19.2	10.4	15.1	42.5	30.6	7.2	18.6	29.3	24.5	17.6	28.7	11.9	35.1	12.1	37.7	17.8	23.2	27.1	33.5	25.8	20.7	19.4	37.1	18.1	23.3	25.1	9.3	28.3	8.7	45.0	15.2	27.2	35.6	18.3	46.4	11.4	13.3	35.5	17.8	25.9	28.3	0.0	4.0	0.0	4.6	7.3	6.6	6.0	5.3	4.8	12.0	3.9	4.4	7.0	0.0	6.6	6.1	12.8	6.6	3.8	4.5	7.8	5.9	9.8	4.7	5.1	7.9	4.7	6.2	6.7	6.0	20.2	17.3	10.5	7.1	9.9	4.2	20.4	2.7	5.7	5.2	5.9	14.6	1.7	15.2	22.6	7.3	2.8	0.0	15.1	21.5	6.6	4.3	1.1	24.5	9.6	11.1	2.9	2.5	2.4	21.2	10.0	6.0	1.7	12.6	2.6	5.2	14.2	0.0	23.3	9.6	4.2	38.8	14.4	9.3	42.5	6.5	4.7	5.7	5.2	5.8
CTPS2		ENSG00000047230	"CTP synthase 2"	Q9NRF8	X	16588003-16712936	"Enzymes, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017437, HPA075930"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA		14000	"Mitochondria, Cytosol"		"HPA017437: AB_1847326, HPA075930: "	"unprognostic (1.40e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (6.57e-3)"	"unprognostic (8.52e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.56e-4)"	10.0	12.0	7.8	11.5	11.9	7.8	13.5	14.3	9.9	17.5	13.3	14.8	10.8	15.6	22.0	10.2	9.6	12.1	11.9	7.2	8.6	7.1	8.1	13.4	8.3	7.9	9.1	6.1	17.9	14.9	22.9	8.5	8.3	9.3	12.8	12.6	14.1	11.8	9.7	5.5	9.2	12.8	14.0	12.3	7.1	11.3	4.4	10.8	11.5	11.8	8.4	10.6	11.8	11.2	1.6	3.3	1.1	6.1	3.8	2.4	1.4	7.6	7.0	11.4	9.5	5.8	4.4	0.1	4.2	3.5	6.8	6.3	7.0	8.0	0.2	13.5	4.3	6.2	6.2	16.0	7.7	8.2	0.0	10.6	4.3	9.8	10.2	3.0	3.1	0.1	4.8	2.6	6.4	5.4	7.7	9.1	0.1	6.1	0.3	6.2	10.1	0.1	2.4	19.6	2.8	8.2	0.1	6.6	2.4	7.3	8.5	7.1	13.1	13.3	1.0	7.6	12.9	18.5	8.9	5.8	3.6	1.9	9.4	3.6	0.2	0.1	25.3	2.8	2.7	3.9	0.4	1.5	1.1	1.3	0.8	2.4	1.6	2.2	1.4	3.3	1.4	1.7	1.7	0.1	3.8	6.1	2.2	2.0	1.4	7.8	11.9	14.3	9.9	8.6	7.1	9.1	6.1	9.3	10.8	8.9	7.0	3.7	5.0	2.9	4.9	5.2	10.2	4.0	9.1	5.2	0.0	2.9	3.3	8.7	2.8	4.9	6.0	0.0	8.4	6.2	3.9	4.8	5.8	7.5	4.5	6.4	10.9	6.7	4.9	5.8	8.3	2.6	8.5	9.0	7.4	3.4	10.3	11.0	3.9	2.2	4.4	6.5	4.1	0.0	0.2	3.3	1.3	3.8	8.1	4.8
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.9"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 186.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 60.9;U-698: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (9.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (6.90e-7)"	"unprognostic (3.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.27e-2)"	8.0	8.3	11.9	30.9	16.8	17.2	6.9	11.4	14.8	5.6	8.6	10.4	2.6	7.6	7.5	4.4	8.8	5.5	6.1	5.5	12.3	13.1	5.8	4.8	9.7	42.8	11.7	10.3	6.0	5.0	3.6	4.2	7.9	11.1	5.9	10.4	6.4	6.3	4.0	6.8	7.9	12.4	7.5	17.6	17.5	8.2	5.6	8.6	80.9	8.3	3.8	39.9	9.5	6.5	27.9	34.2	17.5	12.7	18.5	24.9	25.1	6.7	4.5	9.9	5.9	3.1	5.5	5.7	17.5	6.5	13.9	11.6	2.9	14.8	60.9	7.6	7.2	8.1	3.9	8.8	5.5	18.8	12.9	5.4	12.6	5.2	4.6	3.2	25.1	16.3	2.7	6.7	8.4	5.1	6.8	7.9	17.3	5.0	23.2	15.8	3.9	31.0	9.9	4.7	11.5	5.5	26.4	20.1	4.8	6.9	4.7	8.8	9.4	6.6	12.9	7.7	4.7	5.8	13.2	6.3	15.7	11.8	13.1	9.4	8.8	5.8	49.4	10.9	15.7	11.6	13.1	10.7	17.5	16.2	12.7	20.3	27.9	21.8	20.0	14.3	26.4	23.4	23.5	5.4	18.5	12.1	34.2	24.9	25.1	11.9	16.8	11.4	14.8	12.3	13.1	11.7	10.3	11.1	8.6	0.0	11.3	75.5	8.0	38.1	13.6	4.6	7.6	1.4	3.4	12.2	5.9	9.8	24.9	17.7	0.4	14.3	9.0	186.9	5.6	16.0	12.9	9.5	23.0	5.3	33.7	17.5	20.2	21.5	48.3	1.1	7.8	41.6	43.9	68.5	17.2	14.3	8.9	7.0	9.6	6.1	8.2	6.5	20.6	34.4	28.8	37.9	3.8	61.7	14.3	6.2
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12.0	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7.0	11.4	14.0	3.1	5.9	19.8	12.0	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3.0	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14.0	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4	3.0	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7.0	3.9	12.0	5.0	6.6	2.1	6.7	0.7	0.0	4.4	9.6	6.0	5.0	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0.0	9.9	7.9	8.0	3.3	2.4	5.0	6.2	4.1
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 50.8;Kupffer cells: 129.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1300000			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	24.9	15.4	8.8	17.0	20.9	7.4	18.4	2.0	11.2	17.9	15.6	20.3	6.4	17.0	13.7	10.8	19.0	13.5	20.5	13.3	8.3	6.1	10.5	52.2	26.0	25.7	25.3	7.1	20.4	9.7	15.5	18.4	8.0	13.9	11.6	8.4	6.2	16.7	11.6	6.7	7.7	22.4	15.5	15.0	27.7	12.0	6.0	22.2	27.4	13.5	10.0	10.4	16.3	19.6	2.6	14.3	28.3	28.1	5.7	7.3	8.0	7.7	2.2	2.8	0.0	15.9	27.4	0.0	12.7	11.6	11.8	8.8	0.0	3.3	4.1	18.7	11.7	1.8	1.9	0.0	2.9	21.8	4.0	2.6	3.5	4.2	0.0	7.1	1.5	0.2	21.6	1.1	9.4	10.8	25.1	9.6	2.4	0.1	13.2	6.1	0.0	8.1	2.2	0.3	0.0	2.7	0.0	13.6	6.4	14.5	0.0	4.1	3.2	10.8	0.9	0.1	0.3	0.0	3.5	11.0	25.7	1.8	20.6	25.0	1.1	0.0	0.0	3.7	4.5	20.3	6.3	28.1	1.7	5.5	13.0	7.3	0.9	6.5	5.3	14.3	2.6	6.2	5.4	28.3	5.7	10.7	0.4	7.0	8.0	8.8	20.9	2.0	11.2	8.3	6.1	25.3	7.1	13.9	22.2	14.9	33.7	3.0	8.0	6.8	1.9	3.1	30.6	6.7	12.5	7.0	0.0	0.2	5.0	2.1	5.8	11.7	4.0	0.0	5.5	0.1	11.7	5.8	9.2	50.8	17.3	0.0	2.9	17.8	129.0	2.0	31.1	44.1	3.3	10.0	3.7	4.8	3.9	2.3	17.7	5.6	0.0	12.9	9.5	1.2	1.7	4.8	0.1	10.8	3.0	8.8
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467053	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 42.2;liver: 103.6"	"Group enriched"	"Detected in some"	15	"Hepatocytes: 429.9;Proximal tubular cells: 408.7"	"Group enriched"	"Detected in some"	21	"liver cancer: 57.6;renal cancer: 11.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;HSkMC: 2.4;U-266/84: 2.0;U-698: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024785	Enhanced					NA	NA		89000			"HPA024785: AB_1847856"	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	2.5	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.2	2.1	0.1	0.0	0.0	0.0	1.6	0.1	0.2	1.3	0.0	0.0	0.1	42.2	103.6	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.1	0.9	0.0	0.2	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.7	0.0	0.0	0.0	1.2	0.0	0.0	2.7	0.0	0.1	0.0	0.2	0.0	1.3	1.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.7	0.0	0.1	0.6	1.3	1.4	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.0	1.5	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.4	28.1	0.0	0.0	19.2	0.0	0.0	23.2	0.0	9.9	0.0	0.0	23.3	0.0	0.0	0.6	2.5	0.0	429.9	1.3	0.0	0.0	6.2	6.2	9.7	0.9	0.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	408.7	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514022-26658178	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.0"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 240.0"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 25.5;monocytes: 26.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 61.4;Karpas-707: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		3900000	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (5.41e-5)"	31.6	21.7	53.5	13.4	48.1	3.0	21.3	51.8	137.0	14.6	12.2	54.7	3.9	7.1	14.2	8.1	12.0	14.7	18.0	27.2	52.9	48.6	12.1	11.2	45.3	9.9	56.5	45.4	25.8	7.5	5.1	7.2	25.6	46.9	9.8	12.4	8.2	6.5	10.3	10.9	10.2	9.7	19.9	70.1	19.0	8.5	7.5	44.9	5.8	7.7	5.2	12.3	14.0	13.1	3.2	25.5	0.6	26.7	4.0	4.6	8.8	4.7	23.1	22.8	12.1	61.4	28.3	2.2	9.3	21.8	8.9	11.6	9.0	6.9	7.1	6.8	29.2	18.0	4.6	23.9	9.3	8.5	16.1	2.0	8.1	8.8	12.6	39.4	1.7	3.3	35.1	13.5	24.4	14.2	28.8	17.9	5.6	0.2	63.2	8.9	3.0	13.7	1.7	17.8	15.3	4.5	18.3	9.1	4.7	15.0	5.5	10.4	21.9	11.3	0.1	6.1	15.7	1.7	3.2	32.2	20.3	8.2	16.8	4.0	8.9	9.1	5.6	29.4	10.6	10.3	0.4	24.0	0.2	3.5	26.7	1.2	3.2	3.1	2.3	25.5	1.7	1.6	2.1	0.6	4.0	16.2	15.1	4.6	8.8	53.5	48.1	51.8	68.4	52.9	48.6	56.5	45.4	46.9	44.9	122.1	67.9	17.3	0.8	35.8	104.6	86.8	104.4	17.4	31.8	21.0	29.5	12.9	3.3	17.3	2.6	134.9	3.1	0.0	1.6	9.2	59.6	1.1	19.7	13.4	46.2	133.5	58.3	240.0	207.1	6.4	100.9	92.1	114.7	101.8	73.9	141.1	9.7	3.6	84.1	17.3	36.8	135.8	60.8	3.1	8.5	29.5	3.8	8.7	6.6	1.1
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390811-147510056	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 91.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 312.2;Peritubular cells: 193.4;Rod photoreceptor cells: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 119.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		170000	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	21.7	7.2	22.9	18.9	20.4	0.5	14.1	6.7	31.0	26.8	39.7	20.9	31.4	6.8	38.8	28.0	28.8	20.1	33.9	18.5	23.7	24.7	2.5	1.8	16.2	6.1	16.7	15.2	33.0	2.2	1.0	4.2	7.1	27.0	40.0	14.3	32.3	7.1	61.4	22.1	7.3	12.9	91.4	24.7	9.1	15.0	12.1	15.9	0.3	7.2	15.5	9.6	45.6	18.9	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	6.1	11.0	0.0	0.4	11.3	0.2	5.8	27.8	12.4	16.5	19.1	0.5	0.0	1.6	16.8	6.5	0.6	2.2	0.2	13.8	2.6	5.0	0.0	5.3	0.0	11.2	0.0	0.0	2.1	0.1	26.6	10.5	31.2	35.3	0.0	0.0	0.2	7.0	0.0	0.0	0.1	23.4	0.0	9.1	0.0	23.4	0.0	10.9	2.4	8.2	119.4	0.0	0.0	1.9	15.9	0.1	0.1	15.4	9.0	6.8	22.0	21.3	19.8	3.5	0.0	8.3	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	22.9	20.4	6.7	12.5	23.7	24.7	16.7	15.2	27.0	15.9	0.0	3.2	0.0	2.8	8.4	12.5	5.2	2.5	4.0	5.7	0.0	312.2	0.1	0.0	3.6	14.1	50.5	0.0	0.0	7.4	0.2	38.0	9.9	1.1	0.2	1.5	4.8	6.3	29.4	0.6	13.2	39.7	1.1	18.6	0.0	0.0	22.9	10.7	0.0	193.4	0.0	109.3	0.0	35.1	1.4	2.6	7.2	0.3	0.0	0.0	3.4
DTYMK	"CDC8, TMPK, TYMK"	ENSG00000168393	"Deoxythymidylate kinase"	P23919	2	241675742-241686991	"Enzymes, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042593, HPA042719"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA042593: AB_10959590, HPA042719: AB_10960633"	"unprognostic (1.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (7.13e-2)"	"unprognostic (6.81e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.19e-2)"	12.4	17.6	11.6	17.3	15.0	29.1	14.4	14.5	12.4	10.0	13.8	16.5	9.3	12.0	12.4	9.7	20.0	9.7	10.2	9.4	9.0	6.5	15.5	19.5	10.5	21.0	14.0	9.5	9.5	13.6	5.0	8.8	10.4	11.8	11.5	11.7	10.8	9.6	10.0	6.7	17.9	13.0	13.0	9.5	18.8	13.5	11.1	15.1	20.7	9.4	16.1	17.9	11.7	11.9	19.8	21.1	12.0	24.7	15.7	21.8	15.7	25.1	27.8	24.2	30.7	8.0	8.7	25.6	20.6	15.5	27.5	32.4	12.7	30.5	12.2	6.4	16.6	32.8	21.2	22.2	25.1	14.8	28.7	26.4	26.1	23.3	24.1	6.6	16.5	21.7	6.1	6.8	26.5	10.8	8.4	26.4	17.7	29.4	10.3	29.1	26.2	30.5	28.7	23.8	28.2	23.4	26.1	35.6	17.0	15.9	14.6	29.2	18.3	13.4	20.6	16.5	7.7	18.7	29.6	17.1	40.1	28.8	25.5	38.0	11.6	12.2	34.2	32.1	26.5	46.6	12.0	14.9	9.5	17.4	24.7	16.8	19.2	16.1	18.2	10.5	19.8	16.0	14.7	2.5	15.7	18.8	21.1	21.8	15.7	11.6	15.0	14.5	12.4	9.0	6.5	14.0	9.5	11.8	15.1	8.9	4.3	11.9	17.5	13.5	18.2	9.2	25.5	8.1	11.4	24.4	2.0	48.5	18.3	37.3	1.8	17.5	9.3	46.7	29.4	118.6	22.0	17.5	15.0	16.6	74.0	4.8	13.8	20.9	13.1	2.0	15.3	23.4	21.9	57.7	19.9	16.3	27.3	14.0	18.0	27.5	14.2	25.8	16.1	27.6	57.7	10.5	23.0	15.8	34.8	12.0
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	26.9	32.9	23.2	51.1	31.8	69.0	31.9	31.7	27.6	26.8	26.3	24.4	27.2	14.5	29.8	31.8	33.7	26.9	28.2	35.5	23.2	26.5	25.4	19.8	25.7	44.7	25.3	23.6	33.4	22.2	23.7	30.7	26.0	22.5	30.3	24.3	28.1	27.5	26.1	25.6	27.3	22.6	25.6	23.9	30.1	25.8	31.9	20.7	120.3	40.5	37.7	43.2	23.5	28.4	34.5	32.3	17.0	24.5	22.2	40.2	24.3	26.1	8.2	20.1	19.0	14.1	15.0	12.0	27.8	17.7	25.7	31.9	9.5	18.1	73.0	15.0	15.2	21.0	36.0	21.1	19.0	25.2	51.4	21.8	59.6	21.7	12.9	7.8	62.4	28.4	9.2	12.9	17.4	9.2	16.7	17.0	43.7	32.2	41.5	18.9	10.6	55.8	73.5	12.7	26.7	15.9	45.5	44.0	76.7	16.9	17.8	29.2	29.7	20.6	16.7	23.8	21.4	23.6	49.8	14.1	26.9	26.0	32.0	36.4	33.5	69.7	71.9	20.3	107.2	29.5	11.3	19.5	17.0	21.7	19.3	28.1	34.5	38.9	34.2	28.2	31.6	40.2	26.5	11.1	22.2	24.5	32.3	34.4	24.3	23.2	31.8	31.7	27.6	23.2	26.5	25.3	23.6	22.5	20.7	50.6	29.3	108.7	177.4	159.5	41.9	99.9	84.1	24.1	61.4	99.5	13.7	138.0	172.5	82.7	26.1	112.3	21.0	140.2	40.7	245.0	140.4	116.4	84.1	71.8	150.1	77.9	92.4	100.1	85.2	25.7	171.2	102.9	146.8	57.7	93.4	81.1	44.6	42.1	166.9	204.1	36.1	155.2	162.6	380.2	218.4	147.3	81.2	113.3	168.7	147.0
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Cell type enhanced"	"Detected in many"	20	"Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Group enriched"	"Detected in some"	18	"HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.2	0.0	17.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2	0.0	1.4	0.0	2.8	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	1.3	0.3	9.0	0.0	0.0	0.0	0.5	4.6	33.7	1.7	0.1	0.0	0.0	0.6	0.6	0.0	1.1	0.2	1.7	0.0	1.1	0.0	0.0	2.3	0.7	8.2	0.0	0.0	0.0	1.8	0.8	0.5	0.1	0.5	5.2	1.1
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95869695	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 59.4"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 45.3;Endothelial cells: 46.6;Kupffer cells: 77.1;Macrophages: 80.4;monocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 57.3;Karpas-707: 47.1"									"CAB002494, HPA014067"	Enhanced		Uncertain	Microtubules		NA	NA			Microtubules		"CAB002494: AB_563557, HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	10.4	7.5	7.4	16.2	8.4	15.6	8.8	7.6	6.9	18.9	12.7	13.1	8.7	5.8	59.4	12.8	13.2	15.6	22.2	6.8	7.4	7.4	6.2	3.9	14.8	14.5	8.5	4.9	10.3	2.8	3.0	4.3	24.0	9.9	14.7	9.1	10.8	6.7	12.7	3.3	5.5	12.2	37.2	17.9	25.3	7.5	5.4	7.2	3.5	13.4	12.5	21.1	25.2	12.4	6.0	11.8	37.4	15.2	0.5	5.1	4.6	0.1	0.3	0.9	0.8	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.5	0.1	1.0	0.6	0.0	1.4	0.3	0.0	0.0	0.0	57.3	0.7	0.6	0.4	0.7	0.0	1.5	0.2	0.0	0.0	0.2	0.0	0.3	7.5	0.3	0.6	47.1	0.0	0.6	0.4	1.5	0.6	0.6	0.2	2.4	0.4	0.7	0.5	0.2	0.7	1.1	0.3	1.1	0.8	0.6	0.5	1.6	0.8	0.4	0.2	0.6	0.6	6.7	0.9	0.0	0.6	3.1	0.2	0.1	15.2	37.4	0.1	10.7	0.3	6.0	0.6	0.3	11.8	4.6	0.1	0.1	26.7	0.5	2.4	0.7	5.1	4.6	7.4	8.4	7.6	6.9	7.4	7.4	8.5	4.9	9.9	7.2	0.0	1.4	45.3	0.3	7.9	1.4	8.5	0.0	1.4	1.2	1.8	2.0	0.4	1.7	0.0	5.9	46.6	0.0	0.0	1.8	1.7	8.7	0.4	3.5	0.0	23.2	0.0	0.0	11.6	77.1	6.1	0.6	80.4	15.1	46.9	0.0	0.7	0.2	0.2	2.8	0.3	0.7	6.5	32.0	6.2	4.3	9.8	13.2	14.6	0.4	0.2
ENTPD2	"CD39L1, NTPDase-2"	ENSG00000054179	"Ectonucleoside triphosphate diphosphohydrolase 2"	Q9Y5L3	9	137048098-137054045	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Group enriched"	"Detected in many"	4	"Leydig cells: 178.1;Peritubular cells: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 2.6"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 15.9;hTCEpi: 8.8;MCF7: 11.0;OE19: 17.7;SK-BR-3: 14.8;T-47d: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017676	Approved					NA	NA					"HPA017676: AB_1848179"	"unprognostic (1.64e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.71e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (3.51e-6)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.51e-1)"	"unprognostic (8.43e-2)"	"unprognostic (1.12e-3)"	1.7	1.6	18.8	1.5	10.1	0.6	7.0	4.0	10.4	9.8	9.1	21.9	1.7	17.6	2.8	4.4	3.3	9.4	10.7	2.7	22.6	9.6	4.5	1.0	1.0	0.5	6.1	12.8	0.8	2.6	1.2	3.1	3.9	11.9	11.2	5.8	2.5	6.2	2.9	3.0	9.3	11.1	1.9	7.5	0.5	9.5	6.8	11.7	0.0	0.7	2.6	1.0	0.9	3.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	4.2	1.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.9	0.0	0.0	3.4	0.3	2.5	0.0	0.0	0.1	0.0	0.4	15.9	0.0	0.0	0.2	0.0	8.8	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	17.7	2.4	0.0	0.7	1.6	1.9	0.4	2.4	0.0	0.2	14.8	0.0	0.1	16.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.8	10.1	4.0	9.8	22.6	9.6	6.1	12.8	11.9	11.7	0.0	0.0	0.0	1.1	1.4	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.3	0.0	6.1	1.1	0.7	31.6	0.0	3.9	0.9	1.7	5.9	0.0	0.9	0.2	0.0	24.2	0.6	0.0	2.1	178.1	0.0	5.0	1.0	8.1	7.2	4.5	31.7	90.9	8.4	0.0	0.0	0.4	1.2	4.3	1.3	0.8	0.0	12.8	1.0
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387156-40428619	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.2;pancreas: 37.3"	"Group enriched"	"Detected in many"	4	"Exocrine glandular cells: 19.8;Pancreatic endocrine cells: 5.7;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;HBEC3-KT: 12.7;hTCEpi: 8.6;RT4: 18.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.6	2.2	5.7	1.7	25.9	0.5	2.1	5.4	15.8	26.2	3.3	0.6	1.9	1.7	4.0	4.4	7.5	1.3	3.6	1.4	4.9	6.3	3.6	0.5	4.8	0.9	4.0	6.3	2.6	37.3	1.7	4.2	2.9	14.5	5.3	3.6	2.8	21.2	5.1	1.7	3.2	1.6	2.5	1.7	5.1	8.8	1.3	4.8	0.0	7.0	5.6	4.8	13.7	2.9	0.5	7.4	1.4	0.3	0.9	0.8	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.1	3.8	0.0	12.7	0.3	0.7	0.4	0.7	0.5	0.2	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	0.3	1.6	18.3	1.9	0.4	0.8	1.4	0.3	0.4	0.7	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.0	1.1	0.1	0.1	1.4	0.2	0.0	0.2	0.3	0.8	0.3	0.2	0.3	0.0	0.5	0.6	0.6	0.0	0.9	0.2	7.4	0.6	0.1	5.7	25.9	5.4	15.8	4.9	6.3	4.0	6.3	14.5	4.8	3.0	3.4	0.0	1.0	2.1	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	19.8	0.0	0.2	2.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	5.7	0.0	0.7	0.0	0.6	19.4	3.1	0.3	0.1	1.9	0.0	0.0	0.0	3.7
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA017655	Supported		Approved	Vesicles		NA	NA		28000	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	15.0	21.9	19.8	25.7	15.3	20.3	27.4	15.2	18.5	14.7	15.7	17.0	18.8	17.9	13.3	12.7	14.4	21.0	14.5	12.8	13.0	14.4	19.9	26.0	16.2	12.2	14.7	26.5	30.4	25.2	19.3	20.6	17.6	20.2	18.0	19.5	13.7	14.9	12.2	26.1	16.1	14.5	26.9	19.1	18.7	15.8	17.0	15.8	9.3	30.7	16.7	16.7	9.7	8.0	15.9	9.5	4.4	10.7	6.8	9.3	12.9	16.3	11.2	14.2	18.1	16.6	15.0	14.3	10.2	16.0	18.5	12.5	15.9	10.9	15.1	15.7	11.4	7.3	13.6	19.6	3.8	5.1	8.4	8.0	6.4	11.6	4.4	16.7	11.1	16.6	13.5	14.5	24.9	14.6	12.4	5.8	14.6	17.2	4.2	6.4	5.4	9.5	12.0	4.7	6.4	16.3	4.8	13.0	11.1	13.0	12.4	5.6	8.2	11.0	33.9	6.0	6.3	18.0	18.6	18.4	20.8	11.0	11.7	4.9	20.7	24.9	5.3	18.6	14.9	6.0	13.7	8.5	9.5	10.0	9.7	8.3	9.1	8.0	6.7	10.7	8.3	15.9	4.4	6.9	7.3	6.5	6.8	15.0	19.8	20.3	27.4	14.5	12.8	16.2	12.2	20.6	15.8	17.9	34.6	17.1	9.5	5.8	30.2	20.4	7.6	14.7	28.4	14.0	13.7	12.6	0.0	13.8	6.9	13.7	17.8	23.3	14.7	13.0	12.7	14.2	16.3	10.5	10.5	44.5	16.6	11.1	11.0	15.7	6.6	15.2	11.8	12.6	15.2	18.9	18.1	11.9	8.1	3.7	34.2	12.9	12.3	20.7	21.1	4.8	16.9	15.0	10.5	13.9
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 99.9;Hepatocytes: 120.9;Mucus-secreting cells: 67.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Cell line enhanced"	"Detected in all"		"RT4: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5000000			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.4	4.4	5.0	9.3	10.0	9.5	5.8	5.7	4.7	3.8	4.4	3.3	6.6	6.2	2.9	7.8	3.7	6.5	5.0	8.3	4.3	5.2	2.4	4.6	3.2	18.1	9.7	2.7	5.4	7.7	8.4	5.4	11.2	5.4	7.6	10.2	5.1	9.4	5.6	7.7	3.1	3.3	1.5	4.9	9.6	3.5	4.8	3.0	6.7	34.5	3.6	3.7	9.7	7.7	5.5	4.0	11.1	2.5	6.4	7.7	8.0	4.6	4.2	6.1	9.5	5.0	4.9	5.1	6.9	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5	14.9	7.9	6.7	4.8	3.3	6.1	4.8	12.7	5.3	10.3	7.0	3.9	6.4	21.6	5.1	13.9	5.4	99.9	0.0	11.3	5.7	4.9	39.5	1.1	120.9	5.5	9.5	15.5	11.6	7.0	8.7	2.6	5.1	5.0	6.4	67.4	4.8	7.4	54.7	5.3	50.1	12.0	12.9	4.1	20.1	18.3	3.0	2.7	4.9	41.0	12.3
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6 (putative)"	O75354	20	25195693-25226729	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		18000	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	12.7	19.7	21.8	11.3	46.5	6.7	12.8	33.1	49.1	9.8	31.3	12.1	12.8	31.6	9.4	10.1	9.0	12.5	18.3	27.5	24.9	25.0	13.4	12.9	11.0	7.4	15.1	29.2	16.1	25.6	11.7	20.5	13.2	15.4	25.5	24.5	9.0	36.8	9.7	15.1	6.8	32.2	9.9	8.2	8.3	24.7	16.1	10.5	9.4	10.4	6.1	8.3	10.2	7.1	7.2	17.1	3.0	16.0	8.8	17.9	12.9	20.7	32.9	9.0	17.3	11.4	14.3	19.4	17.1	12.4	14.8	13.7	17.6	16.1	12.6	25.8	16.4	29.0	27.2	11.0	26.0	9.9	7.7	9.8	10.2	5.0	39.7	17.1	13.6	15.8	13.4	14.5	18.7	14.2	10.9	11.9	12.3	13.3	22.0	11.0	19.9	12.7	8.4	5.7	17.3	25.8	7.2	28.2	28.8	18.6	13.0	14.4	7.5	4.7	28.9	76.8	8.7	21.1	11.5	12.8	17.3	18.0	14.2	20.1	13.8	11.1	5.5	12.4	9.0	32.5	0.0	16.0	3.0	12.7	10.7	17.9	6.1	11.4	10.4	17.1	7.2	12.2	10.6	0.7	8.8	4.8	12.0	10.6	12.9	21.8	46.5	33.1	49.1	24.9	25.0	15.1	29.2	15.4	10.5	17.9	31.6	13.4	14.5	8.8	16.7	4.3	28.1	8.1	7.9	17.4	9.8	53.2	8.3	33.5	18.1	5.8	66.6	0.0	35.1	18.5	10.3	22.0	3.5	13.0	22.9	23.8	32.6	17.2	15.4	46.1	19.0	16.9	10.1	17.2	55.2	3.9	28.8	57.5	39.6	11.0	7.9	6.5	5.9	3.2	9.1	5.3	50.0	8.4	60.2	10.1
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Group enriched"	"Detected in some"	6	"Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	1.6	0.0	0.2	0.1	3.0	0.4	0.0	0.0	8.8	1.4	0.0	0.3	0.9	0.2	0.0	0.1	0.7	4.8	0.2	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	12.7	0.0	0.0	19.2	0.0	0.0	0.0	0.8	0.0	0.0	107.0	0.0	6.8	0.1	0.0	1.0	0.0	8.2	0.1	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	160.6	0.0	0.5	49.1	0.0	4.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	12.7	0.6
FAM20B	"GXK1, KIAA0475"	ENSG00000116199	"FAM20B, glycosaminoglycan xylosylkinase"	O75063	1	179025804-179076562	"Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007409	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		280000	"Golgi apparatus"	Nucleoplasm	"HPA007409: AB_10601649"	"unprognostic (7.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.74e-1)"	18.2	21.3	17.7	12.8	20.9	8.8	26.0	16.1	26.4	15.8	20.8	10.8	13.3	8.7	18.5	14.7	17.5	14.7	17.3	32.9	17.1	17.2	16.2	14.8	14.6	9.1	16.1	19.9	19.0	10.1	22.5	16.9	15.2	15.2	15.6	13.4	14.5	9.9	18.8	19.0	11.4	10.6	25.9	13.6	10.5	14.4	6.8	9.4	7.3	16.5	7.7	9.4	17.6	28.7	4.9	3.6	2.3	2.3	4.4	4.1	1.5	17.9	16.5	12.8	13.5	22.9	24.2	14.2	15.0	17.2	10.6	9.5	8.2	18.0	9.3	19.8	26.4	8.7	13.2	13.0	11.0	15.6	11.8	8.8	29.7	15.6	10.4	11.4	19.6	18.8	14.0	12.1	14.4	11.2	16.2	13.0	13.1	33.0	13.7	16.9	10.0	8.5	7.1	16.8	20.3	3.5	10.5	13.5	12.4	8.9	20.4	17.1	42.1	15.8	18.0	15.3	19.0	15.5	14.4	13.7	16.9	14.9	23.2	20.2	11.2	20.4	8.2	16.8	9.6	16.7	2.3	2.0	0.6	3.8	1.7	4.1	4.2	2.4	3.5	2.2	4.9	3.5	3.2	1.9	4.4	2.3	3.6	2.7	1.5	17.7	20.9	16.1	26.4	17.1	17.2	16.1	19.9	15.2	9.4	6.0	10.7	11.2	8.9	13.9	12.3	31.9	17.8	8.1	7.9	17.4	23.6	8.0	3.3	8.2	4.2	11.2	4.1	0.0	11.0	5.7	12.4	14.8	16.2	12.2	6.9	36.5	13.8	10.4	8.9	2.5	16.4	6.9	15.1	10.0	7.6	7.8	11.0	0.0	20.1	5.4	20.2	12.9	20.3	12.9	15.8	11.3	6.3	6.9	6.6	23.8
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.4"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;RH-30: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054971			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		110000	"Nucleoplasm, Nuclear bodies"		"HPA054971: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.5	10.3	5.4	6.5	5.7	1.4	4.6	23.2	5.5	4.9	5.1	4.4	10.1	4.9	9.6	26.1	4.5	7.0	8.6	7.6	3.7	5.0	13.0	45.4	7.8	5.2	6.2	3.3	3.8	8.4	9.9	7.4	2.7	4.4	5.7	4.7	6.8	7.6	8.8	26.0	3.7	7.6	6.3	3.0	3.4	3.8	2.9	3.4	4.5	5.4	4.3	6.9	6.2	3.7	8.2	3.6	3.9	4.8	4.7	8.0	3.0	2.8	0.9	6.1	2.5	3.0	10.8	0.5	2.5	4.3	1.5	2.2	0.0	2.2	3.4	8.3	6.8	2.7	1.2	1.0	7.6	3.1	26.8	0.7	2.3	2.0	5.4	8.0	1.3	1.5	15.2	6.4	3.1	5.0	6.4	2.9	3.9	1.6	2.1	9.7	3.3	1.8	2.0	3.8	8.3	3.3	4.0	18.6	1.3	8.1	5.5	4.7	2.0	3.5	2.1	7.3	5.4	1.7	1.4	2.8	2.5	1.9	2.9	1.7	4.9	1.7	2.9	8.3	5.6	2.3	2.6	2.2	2.2	5.4	2.3	5.0	8.2	2.6	6.6	3.6	6.8	4.8	8.0	3.9	4.7	4.8	1.8	4.5	3.0	5.4	5.7	23.2	5.5	3.7	5.0	6.2	3.3	4.4	3.4	50.6	181.0	3.7	19.6	18.5	9.2	20.3	349.1	56.2	27.3	12.2	11.8	7.6	14.9	35.1	12.9	6.3	8.8	0.0	38.7	3.8	4.5	19.5	9.3	122.9	10.8	7.9	2.4	6.7	8.0	8.9	1.7	8.5	33.7	16.2	9.9	11.7	15.0	7.8	2.8	34.0	15.5	0.0	4.4	3.9	7.9	27.6	3.8	2.9	16.3	26.4
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735575-82751197	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 45.2;Distal tubular cells: 76.3;Rod photoreceptor cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;Hep G2: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		1400000	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	12.0	29.4	25.7	3.1	32.7	8.9	5.0	24.8	48.1	10.0	11.0	44.8	6.4	19.4	7.8	7.0	4.7	11.9	6.6	38.1	24.7	22.8	41.7	34.7	7.4	2.6	28.9	25.3	14.0	14.9	17.9	11.9	5.2	34.2	10.4	8.8	11.4	24.6	11.9	14.8	5.0	12.4	6.6	30.8	4.4	10.7	4.6	25.3	0.0	8.2	3.5	2.7	5.6	4.5	0.2	0.0	0.0	0.0	0.9	0.4	0.2	0.6	8.2	2.3	12.1	3.7	3.1	1.5	1.5	1.1	2.8	1.4	10.7	1.7	0.1	2.1	1.3	2.4	0.3	17.8	1.3	1.0	0.5	1.2	6.3	6.8	33.0	10.1	0.1	5.3	2.6	4.7	1.1	0.0	3.0	5.5	0.5	11.1	0.3	0.5	0.9	0.1	0.1	1.5	3.8	6.8	1.0	0.2	0.0	6.0	2.3	3.7	11.9	2.7	0.6	7.7	2.1	8.0	2.3	1.2	0.2	0.8	2.9	2.2	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	25.7	32.7	24.8	48.1	24.7	22.8	28.9	25.3	34.2	25.3	3.0	1.3	1.4	2.7	1.3	35.7	5.1	2.5	1.4	2.3	29.6	45.2	9.7	76.3	3.2	0.0	2.1	9.2	0.0	1.0	1.9	4.3	3.2	1.1	4.7	6.5	30.2	5.2	4.9	1.2	0.0	4.9	2.0	11.8	1.0	10.1	26.8	2.2	7.0	2.8	38.4	70.5	0.0	5.1	0.3	3.6	1.6	7.0	1.3	8.6	3.0
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716683-82730328	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm		NA	NA		14000	Nucleoplasm		"HPA056172: AB_2683055, HPA065831: AB_2685565"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	17.6	18.3	27.9	10.8	26.3	12.3	15.7	19.5	27.3	15.3	17.4	27.4	10.0	11.8	18.4	16.7	16.4	16.6	13.0	12.7	26.1	20.8	18.8	23.1	12.8	12.9	25.7	23.0	21.9	15.3	10.8	11.4	17.1	22.2	17.1	14.4	13.2	17.2	20.0	7.3	16.1	13.6	20.3	30.7	13.7	12.6	8.8	21.6	8.2	15.1	9.8	17.5	12.1	12.9	16.5	23.2	18.5	15.5	18.5	23.0	17.1	10.9	44.3	12.1	16.0	5.9	11.3	10.0	20.6	11.5	19.9	16.3	23.4	7.7	9.0	13.8	16.6	18.4	12.6	11.0	15.6	18.0	6.0	19.5	15.1	24.8	26.9	10.5	10.5	8.5	10.4	18.5	18.9	10.4	12.2	14.3	12.8	14.5	5.7	25.4	20.8	20.5	15.6	5.5	24.1	19.3	15.4	30.8	14.0	14.1	21.1	10.1	21.5	34.0	15.4	16.6	21.9	25.7	15.3	12.6	38.7	13.3	27.3	30.3	11.7	12.8	22.4	18.0	13.4	17.8	17.0	14.2	18.5	20.4	15.5	20.0	15.7	19.9	19.5	11.7	16.5	23.0	16.7	2.1	18.5	8.4	23.2	18.6	17.1	27.9	26.3	19.5	27.3	26.1	20.8	25.7	23.0	22.2	21.6	11.9	12.0	13.7	25.9	13.4	17.8	5.2	20.4	10.7	12.5	10.4	7.9	80.4	19.9	17.2	1.3	11.7	9.5	23.3	9.9	35.3	15.1	14.6	12.7	9.0	28.7	3.2	7.5	11.6	9.4	2.3	26.2	11.8	21.9	28.9	13.3	29.2	14.9	17.3	29.7	15.8	14.3	12.9	17.6	9.7	22.6	13.4	52.3	14.9	16.9	21.3
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		69000	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	17.7	27.5	18.6	24.7	21.2	20.4	17.7	10.2	22.7	21.3	21.4	18.3	20.6	22.9	18.1	17.3	31.0	26.6	19.6	25.9	18.1	13.5	22.9	20.3	22.7	30.6	20.5	24.1	16.5	43.8	17.6	10.2	17.0	16.2	14.6	16.8	13.2	19.9	21.5	19.5	23.4	19.0	16.3	16.3	20.6	19.3	16.7	19.5	15.2	24.9	29.0	24.1	14.6	17.7	19.3	30.7	11.3	31.0	24.7	24.1	18.2	32.7	25.9	12.8	13.3	8.5	12.6	8.5	14.9	20.7	19.6	17.2	20.7	30.5	14.1	13.6	13.6	19.2	28.5	17.6	22.3	13.7	9.2	26.3	35.3	10.7	31.4	16.1	15.1	12.0	12.0	17.1	18.4	11.5	8.1	14.9	11.4	24.2	9.7	17.5	15.0	17.8	43.9	21.4	37.0	26.2	17.1	17.8	37.0	26.8	10.4	19.4	22.9	11.7	41.1	27.3	5.9	17.1	25.2	10.4	22.0	12.3	14.4	31.4	14.5	18.2	26.7	10.2	28.0	23.9	11.3	25.7	8.8	20.7	31.0	18.0	19.3	18.9	21.8	30.7	17.8	14.2	17.2	1.4	24.7	21.9	28.3	24.1	18.2	18.6	21.2	10.2	22.7	18.1	13.5	20.5	24.1	16.2	19.5	20.8	43.1	32.8	43.8	35.6	18.3	8.0	40.8	26.8	37.5	41.8	13.7	62.7	49.7	88.7	2.3	18.6	41.6	0.0	90.9	108.9	44.0	43.6	41.5	32.1	103.0	4.8	26.4	29.4	43.0	2.3	28.7	50.7	38.8	123.6	48.5	17.1	82.5	52.6	20.8	63.4	20.3	19.4	36.4	14.6	19.4	43.0	47.0	46.3	66.6	52.1
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	46.6	93.2	32.2	44.9	13.5	21.6	54.1	36.4	25.3	75.5	57.3	73.3	28.3	82.1	38.0	33.6	30.0	25.1	61.5	61.9	64.6	39.8	82.8	53.8	72.4	101.8	27.4	59.0	24.7	20.5	39.0	56.8	53.2	13.3	45.5	26.4	79.4	27.3	44.7	79.0	70.1	67.8	38.6	103.3	85.0	43.0	63.6	75.6	57.9	32.6	44.7	51.5	19.1	52.3	33.9	28.8	54.4	39.9	28.6	48.7	44.2	30.3	74.7	35.2	81.2	96.7	29.5	50.1	37.0	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3	29.8	22.5	33.5	67.6	117.7	287.4	27.7	63.7	36.1	59.1	68.0	269.0	166.3	127.6	180.3	23.8	58.6	14.6	46.7	172.7	210.0	82.7	60.4	46.0	102.6	183.6	38.1	86.1	27.0	26.9	65.0	56.7	62.9	123.2	55.9	70.8	61.6	165.1	38.6	55.2	140.8	268.7	12.9	66.0	19.8	83.3	116.3	74.0	40.6	110.8	81.0
NME1-NME2	"NM23-LV, NMELV"	ENSG00000011052	"NME1-NME2 readthrough"		17	51153590-51171744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 41.6;Basal keratinocytes: 34.1;Ciliated cells: 25.4;Club cells: 45.5;granulocytes: 20.9;Melanocytes: 21.9;Suprabasal keratinocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB002169, HPA008467, HPA041113, CAB076057"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (5.13e-2)"	"prognostic favorable (6.66e-4)"	"unprognostic (2.46e-2)"	"unprognostic (4.82e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.58e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-6)"	"unprognostic (1.84e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	12.8	29.3	19.7	35.5	16.7	20.6	8.5	13.9	31.2	5.4	7.2	6.7	4.9	14.7	10.6	6.2	10.6	7.4	6.8	8.0	23.0	17.0	10.4	31.3	7.8	18.3	16.9	18.7	8.1	24.1	6.5	11.4	13.6	21.5	6.7	5.7	7.7	23.5	4.7	10.1	8.2	10.7	11.7	11.0	11.9	14.8	5.8	5.6	10.0	8.6	17.9	12.7	9.5	7.6	19.6	37.6	1.0	21.1	14.6	21.9	16.2	29.0	2.0	9.4	34.6	8.8	4.5	7.4	23.0	7.5	6.1	3.8	3.8	19.6	17.0	24.1	11.8	15.3	18.1	9.2	14.8	4.0	25.6	13.8	14.1	3.5	7.3	10.7	23.8	23.5	8.1	11.1	7.7	11.0	14.3	9.7	17.0	11.1	22.0	3.8	4.8	58.2	16.4	28.2	34.6	2.9	34.5	23.1	50.3	7.1	3.8	30.4	17.8	12.1	52.6	26.4	14.4	53.8	40.4	19.4	38.8	28.3	37.6	47.0	37.7	40.7	33.1	22.3	17.2	33.3	0.2	15.1	0.3	15.0	21.1	21.9	19.6	14.7	16.1	37.6	18.4	13.7	16.8	1.0	14.6	11.6	25.7	13.7	16.2	19.7	16.7	13.9	26.4	23.0	17.0	16.9	18.7	21.5	5.6	14.9	41.6	0.0	0.0	34.1	0.0	1.7	0.0	25.4	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	20.9	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.3	8.1	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	45.4	0.0	0.0	0.0	0.0
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 115.1;Club cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	89.1	131.0	31.4	54.7	70.2	102.4	86.6	61.8	64.3	94.6	72.1	105.7	47.5	75.0	100.2	63.3	48.6	57.1	65.8	84.3	78.0	90.4	194.5	63.0	91.4	153.0	76.6	99.5	44.2	92.6	98.5	61.0	107.4	67.1	56.3	53.7	86.3	50.6	68.1	158.5	49.8	124.4	46.7	205.0	201.3	47.8	104.0	119.7	102.4	112.7	71.5	44.3	38.0	95.6	92.8	61.7	65.9	76.3	57.1	91.3	66.0	64.8	98.2	88.4	114.8	85.9	49.3	50.7	45.7	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4	26.8	56.3	13.7	6.1	12.9	0.9	0.0	22.9	115.1	150.2	5.2	0.0	10.6	31.5	37.0	0.4	14.4	5.6	23.3	30.1	24.4	10.8	3.7	39.5	37.1	14.9	0.0	14.0	31.9	41.2	1.1	23.9	13.6	10.1	88.4	24.3	0.2	47.4	14.0	12.0	26.2	0.8	6.5	5.7	0.5	5.0	13.0	7.3	18.1	29.3	6.8
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		7900000	Nucleoplasm	Cytosol	"HPA041113: AB_2677305, HPA052733: AB_2681930"	"prognostic favorable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.7	0.2	9.6	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	14.0	0.1	19.2	0.9	1.2	10.0	0.6	3.8	0.1	13.7	31.3	0.0	5.5	5.5	5.2	2.3	4.4	6.4	3.5	1.2	0.7	2.3	2.5	0.1	4.7	1.9	1.2	17.0	0.2	4.6	12.5	2.3	9.5	6.5	0.1	18.3	2.0	0.5	13.7	10.6	20.7	15.6	1.7	0.5	14.9	5.6	8.7	2.6	9.7	8.3	4.6	5.0	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6	32.8	63.8	51.1	124.1	64.5	115.4	25.8	76.5	58.9	55.7	120.4	56.9	65.8	51.4	53.1	16.8	69.7	85.0	0.0	33.3	35.7	82.8	109.1	50.7	52.9	65.1	62.0	130.1	72.4	57.8	13.2	138.4	78.5	77.6	175.9	94.2	102.4	38.5	89.7	119.9	123.2	117.3	116.4	86.4	1.4	41.7	57.3	38.6	61.8	96.6	69.8
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria		Yes	No			Mitochondria		"CAB045997: AB_11126630, HPA072588: AB_2686538"	"unprognostic (3.27e-1)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavorable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	34.5	34.4	21.5	13.9	17.6	46.8	34.6	10.4	13.6	25.6	44.6	12.8	40.7	9.7	21.7	33.7	25.1	20.0	39.9	26.9	16.6	16.5	20.2	61.2	13.5	27.5	16.9	11.3	31.9	19.2	22.0	17.3	19.4	11.7	46.9	10.6	32.2	44.4	44.0	13.7	7.5	15.3	83.9	12.4	17.8	27.1	13.3	10.9	19.6	21.0	14.2	14.5	64.1	27.5	13.1	28.6	18.2	6.3	1.2	13.7	5.2	0.1	50.4	44.8	61.6	18.0	31.6	10.0	23.7	28.6	35.9	30.9	33.6	29.3	0.5	17.9	37.8	13.0	0.6	24.2	25.5	10.6	20.3	36.2	24.4	6.9	44.9	34.0	17.8	9.0	40.6	13.4	22.0	2.1	25.9	23.0	35.1	25.3	4.3	26.7	41.3	15.5	22.4	45.7	12.3	11.2	78.4	10.0	12.7	24.9	0.2	13.1	71.0	6.0	0.4	22.1	17.2	30.0	41.8	28.7	25.7	37.4	17.1	5.9	0.5	0.3	13.3	11.2	3.2	29.6	4.1	6.3	18.2	7.5	5.6	6.5	12.3	7.7	8.3	8.7	13.1	13.7	7.1	2.2	1.2	4.8	28.6	0.4	5.2	21.5	17.6	10.4	13.6	16.6	16.5	16.9	11.3	11.7	10.9	0.0	11.5	29.0	48.4	28.6	13.9	34.0	35.7	4.0	4.5	55.8	2.0	59.9	212.2	109.2	3.5	43.9	11.0	186.9	35.0	20.4	74.3	109.3	29.9	119.9	107.7	7.9	43.4	47.9	41.0	14.6	82.6	23.2	59.1	66.7	34.5	18.6	75.4	17.3	89.1	59.0	5.4	51.8	95.1	1.4	43.5	21.5	18.2	14.9	56.3	48.5
NME5	"nm23-H5, RSPH23"	ENSG00000112981	"NME/NM23 family member 5"	P56597	5	138115172-138139443	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 28.1;testis: 36.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035648, HPA044555, HPA058103"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nucleoplasm, Nuclear bodies"		"HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: "	"unprognostic (2.49e-2)"	"unprognostic (7.63e-4)"	"unprognostic (9.97e-2)"	"prognostic favorable (7.24e-5)"	"unprognostic (3.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (9.14e-4)"	"unprognostic (1.11e-3)"	"unprognostic (3.45e-1)"	"unprognostic (3.16e-2)"	1.3	5.2	12.3	0.6	18.4	0.3	3.7	3.5	13.9	7.1	1.2	3.9	4.7	0.5	4.1	18.2	1.0	28.1	6.8	2.9	12.0	10.7	15.4	0.6	3.6	0.6	9.4	9.9	4.5	3.5	12.1	8.9	0.4	13.1	4.2	1.1	4.8	3.1	3.9	0.4	0.4	0.5	2.6	4.2	0.4	2.2	36.2	4.8	0.0	9.6	0.3	0.4	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	0.0	0.0	0.0	0.6	0.4	0.6	0.2	0.1	1.5	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	1.9	0.0	0.8	0.0	3.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	25.6	0.0	5.9	2.2	0.0	0.7	3.8	1.5	0.5	1.3	0.0	0.6	0.0	0.0	0.8	0.4	0.6	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	18.4	3.5	13.9	12.0	10.7	9.4	9.9	13.1	4.8	6.0	6.9	0.0	9.1	0.6	11.4	2.8	2.5	327.9	26.1	31.4	13.7	0.4	72.9	18.8	516.0	3.4	0.0	0.0	3.6	0.0	3.2	7.9	0.0	0.5	0.1	6.4	5.2	1.3	0.0	184.0	8.3	0.7	10.1	1.0	2.5	15.8	5.2	0.0	13.1	66.5	21.6	0.0	1.0	142.0	20.4	0.3	0.0	0.0	1.1	5.6
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017909	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	11.7	12.2	7.0	14.4	11.0	7.7	13.5	9.2	10.9	12.2	12.0	11.9	14.6	13.5	16.1	13.2	16.1	16.3	8.8	13.7	9.9	6.8	18.0	17.5	11.1	12.9	9.2	10.3	14.5	20.6	12.1	13.3	22.1	8.8	13.2	12.7	13.5	20.8	17.6	20.1	10.3	13.4	13.3	7.1	14.2	13.4	9.0	8.2	12.6	17.5	14.3	15.1	13.9	15.7	26.4	23.5	43.3	22.7	23.0	25.8	14.3	17.9	11.2	15.3	11.1	12.5	16.8	13.7	17.6	13.6	25.9	19.7	18.7	15.8	18.1	9.2	13.7	24.3	6.3	13.7	19.4	15.4	21.6	13.3	11.8	15.0	15.2	16.7	14.9	12.7	13.7	21.3	23.0	27.4	12.4	13.9	13.7	19.7	14.0	9.7	8.5	12.5	6.4	12.9	12.7	14.7	7.4	13.4	15.2	13.0	15.5	4.7	8.1	12.0	13.2	15.7	12.4	14.8	13.9	12.4	5.1	20.4	12.7	25.0	16.6	22.4	16.3	9.7	19.8	11.3	22.0	20.1	43.3	25.8	20.7	23.6	26.4	24.2	21.9	23.5	24.4	18.7	17.7	22.5	23.0	22.7	21.1	19.4	14.3	7.0	11.0	9.2	10.9	9.9	6.8	9.2	10.3	8.8	8.2	26.8	20.2	17.6	7.9	4.4	12.2	9.2	20.4	44.2	21.6	8.7	13.7	42.3	33.2	22.4	1.9	8.3	11.2	0.0	26.1	34.3	7.8	7.3	9.3	8.3	29.6	9.5	4.1	6.7	6.7	1.5	10.9	12.4	15.1	29.7	8.8	14.6	25.4	7.0	6.7	12.8	12.2	12.9	7.4	9.1	13.2	3.6	16.5	13.8	12.8	5.9
NME7	"CFAP67, FLJ37194, NM23-H7"	ENSG00000143156	"NME/NM23 family member 7"	Q9Y5B8	1	169132531-169367967	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038014, HPA054289"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA038014: AB_10673037, HPA054289: AB_2682437"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.44e-3)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	7.7	12.1	13.5	8.0	22.8	3.7	12.8	14.6	16.8	15.6	11.5	5.5	13.4	4.6	16.0	15.8	8.6	31.1	11.2	8.4	18.9	11.3	13.9	8.6	8.9	6.0	9.5	11.5	17.0	8.1	18.9	39.9	5.6	15.6	9.6	6.7	9.3	5.9	14.3	5.1	4.9	5.5	17.2	9.5	5.2	8.1	17.2	9.6	11.9	15.9	5.8	7.0	10.0	8.2	8.5	5.2	1.7	7.1	9.1	12.0	4.7	10.5	11.3	12.3	9.6	12.4	12.5	4.4	7.3	11.1	13.3	16.9	6.4	16.0	3.1	13.4	6.5	18.4	7.4	6.9	15.8	21.8	11.0	5.7	5.6	10.8	6.5	8.5	10.2	3.6	9.1	9.6	13.4	18.2	19.2	19.0	9.6	5.3	4.3	13.3	3.4	9.2	7.5	12.1	12.7	11.6	7.2	13.3	6.8	21.6	3.1	13.3	19.2	11.1	3.3	8.2	14.4	11.4	7.4	11.4	8.3	27.5	7.3	17.7	5.2	8.8	6.5	9.1	3.6	8.2	1.4	3.3	1.7	8.3	5.1	10.1	8.5	10.8	8.8	5.2	7.0	9.3	10.6	1.0	9.1	7.1	4.4	12.0	4.7	13.5	22.8	14.6	16.8	18.9	11.3	9.5	11.5	15.6	9.6	6.0	7.5	8.2	29.3	12.8	17.2	4.1	15.3	72.3	15.9	26.2	23.6	6.8	19.9	22.8	19.4	13.7	2.6	0.0	7.9	6.3	18.5	7.6	20.8	10.4	12.0	27.0	16.8	11.1	4.0	7.9	16.7	8.2	8.5	2.8	3.9	18.0	13.9	6.0	19.4	30.7	61.3	19.4	17.5	51.2	20.0	8.9	2.3	14.1	6.6	17.3
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.4	4.2	12.6	5.6	3.4	4.5	5.1	3.3	5.3	5.6	10.1	7.0	14.3	6.1	5.7	4.6	6.8	8.4	6.9	9.2	5.8	4.5	9.7	11.4	7.9	5.6	8.2	5.4	4.9	2.1	11.3	9.9	3.1	6.2	6.4	11.4	6.0	5.4	8.9	8.0	7.4	5.7	4.0	7.2	10.2	9.8	6.7	4.2	4.8	8.1	3.7	7.9	10.0	6.2	4.5	6.5	3.8	8.1	8.5	6.9	6.0	8.5	5.1	4.8	26.1	7.9	9.2	4.0	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2	17.9	17.9	11.5	5.7	13.7	15.8	12.1	10.2	9.4	7.9	7.0	13.7	13.0	13.3	8.4	4.6	11.3	5.8	0.0	7.4	11.0	11.7	4.8	4.7	11.6	7.8	9.5	6.4	17.2	11.4	13.3	8.9	6.5	1.7	10.0	11.7	7.2	7.8	7.0	12.0	7.8	17.0	0.0	11.1	10.8	19.7	12.9	10.6	15.7	11.8	5.3
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131795	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021581, HPA023632"	Approved		Supported	Cytosol		NA	NA		600000	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (7.66e-4)"	14.5	16.7	10.7	32.5	10.5	14.4	15.2	16.0	13.8	16.3	27.3	18.5	16.2	25.1	18.0	18.7	21.6	15.9	21.0	16.7	9.6	11.0	21.0	13.5	19.9	30.1	12.3	11.0	19.7	28.0	10.4	9.7	11.6	10.9	17.5	14.2	18.0	17.9	17.7	27.1	16.0	30.1	16.7	13.7	20.5	24.5	11.4	12.0	17.2	22.0	30.4	24.5	20.5	17.1	30.7	16.8	46.7	15.8	22.7	14.3	9.7	21.0	33.1	10.9	11.4	3.3	6.9	15.0	12.6	11.0	12.7	8.1	12.3	24.9	14.7	9.2	8.8	2.3	14.8	7.6	15.7	7.3	6.9	23.9	16.1	25.7	20.6	16.5	15.6	7.4	10.0	7.5	9.1	25.5	5.2	14.1	11.7	15.7	7.2	13.0	21.2	11.4	15.9	11.2	18.3	22.0	10.4	14.3	20.4	16.5	11.4	12.9	26.5	12.1	15.0	17.4	6.5	21.0	11.5	8.1	11.1	27.5	4.2	16.6	14.3	2.1	16.3	10.3	9.6	17.2	46.7	10.2	15.2	13.8	15.8	9.7	30.7	9.0	11.6	12.7	29.1	7.9	11.9	4.6	22.7	15.5	16.8	14.3	9.7	10.7	10.5	16.0	13.8	9.6	11.0	12.3	11.0	10.9	12.0	29.8	21.6	121.5	83.2	42.1	67.1	15.5	94.3	9.4	11.4	55.8	19.6	58.2	66.3	80.9	1.6	21.2	215.1	0.0	106.1	86.7	57.7	61.8	46.1	34.2	66.0	39.7	61.5	16.5	50.0	3.3	55.0	59.6	55.6	144.3	82.5	46.3	97.1	133.3	44.6	119.5	63.7	32.3	67.0	20.7	54.1	38.8	26.1	67.1	96.4	63.4
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 51.9;tongue: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"SH-SY5Y: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA050283, HPA054158"	Supported					NA	NA					"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.7	2.8	1.2	0.8	3.0	0.5	0.5	5.6	7.6	0.7	0.5	1.0	0.0	0.5	0.6	2.9	3.0	0.7	0.5	9.8	1.7	1.7	0.9	0.5	0.5	0.5	1.8	4.9	0.7	6.0	0.5	0.5	0.5	6.9	0.9	0.5	0.0	0.7	0.7	51.9	0.5	0.6	0.6	5.2	0.5	0.6	0.7	1.0	0.0	0.5	13.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	20.4	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	5.6	7.6	1.7	1.7	1.8	4.9	6.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 52.6"	"Group enriched"	"Detected in some"	90	"Early spermatids: 137.7;Late spermatids: 218.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA056683	Uncertain					NA	NA					"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.5	52.6	0.1	0.1	0.5	0.1	0.1	0.5	0.1	1.2	3.7	0.0	0.1	0.7	2.6	0.4	3.2	0.7	0.3	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	3.5	1.6	0.5	0.0	2.2	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.6	0.1	0.0	0.0	0.2	0.0	3.3	0.0	0.5	1.1	0.2	0.0	2.9	0.1	0.2	0.6	0.6	1.6	0.3	0.7	0.8	0.1	2.9	2.4	1.2	2.6	0.4	1.5	0.4	0.7	0.7	1.6	1.5	1.0	2.9	0.5	1.0	0.7	2.0	2.5	0.0	1.2	0.0	0.1	0.0	1.3	0.0	2.3	0.1	1.3	1.3	0.3	1.2	2.6	2.2	0.0	0.7	0.1	3.7	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0
NT5C1B-RDH14		ENSG00000250741	"NT5C1B-RDH14 readthrough"		2	18555545-18589564	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	74	"testis: 49.4"	"Group enriched"	"Detected in some"	76	"Early spermatids: 43.1;Late spermatids: 43.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"TIME: 1.1"									HPA056683	Uncertain					NA	NA					"HPA056683: AB_2683207"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103088017-103193306	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA					"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	15.0	17.0	17.6	18.2	21.2	31.6	19.7	22.5	19.6	17.5	20.7	25.4	24.5	10.9	24.6	19.6	38.6	14.8	17.0	16.5	16.7	20.7	19.6	15.5	18.8	16.8	21.8	17.3	24.8	19.4	18.7	29.5	16.9	29.1	22.9	17.0	26.2	67.2	21.6	41.6	11.7	13.9	20.4	19.1	20.5	15.9	21.7	14.5	29.7	39.2	16.3	31.5	21.1	31.1	6.7	9.7	23.8	14.5	10.5	8.7	7.1	50.7	20.7	14.4	32.3	12.7	14.1	8.3	25.5	24.8	12.4	12.9	15.0	40.7	24.3	19.8	17.6	10.8	26.0	9.5	13.1	14.6	14.6	8.9	17.5	8.8	14.5	22.7	25.3	8.7	21.7	14.6	10.8	17.5	30.2	11.4	11.8	11.3	17.0	21.5	30.0	22.6	32.8	13.6	15.5	25.6	36.9	12.4	7.0	17.8	29.0	4.3	10.8	13.4	10.6	20.0	20.4	16.1	19.7	11.6	9.9	10.0	14.1	18.6	14.9	24.7	32.6	10.0	29.3	2.8	19.8	11.7	23.8	8.1	11.9	8.7	6.7	7.0	6.5	9.7	4.2	6.0	6.2	21.4	10.5	14.5	7.3	6.5	7.1	17.6	21.2	22.5	18.0	16.7	20.7	21.8	17.3	29.1	14.5	77.4	27.5	10.4	26.3	6.5	19.9	2.4	20.4	32.1	67.1	26.2	43.2	16.3	10.0	27.7	82.0	15.7	21.6	0.0	22.4	10.0	11.0	32.1	8.1	14.9	17.8	44.5	11.1	12.3	30.0	49.8	23.0	20.7	25.3	13.6	16.7	78.8	41.7	14.2	12.7	13.9	53.0	32.3	12.6	23.0	21.5	6.6	29.3	16.6	13.3	73.2
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014113-33062797	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010630, HPA029058"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.3	12.1	9.9	17.0	9.9	15.4	11.4	16.2	12.2	12.0	27.5	7.4	8.1	20.9	14.7	11.6	12.0	9.0	12.9	11.6	9.8	10.3	11.7	10.5	11.6	15.0	10.3	9.8	10.3	19.1	5.5	10.9	10.6	8.4	9.6	27.2	8.5	9.0	8.9	53.3	15.0	19.7	7.5	9.9	18.4	14.5	6.3	8.9	15.4	9.8	28.8	22.8	12.0	11.6	21.4	6.8	36.6	11.4	8.6	18.9	13.3	14.3	10.5	9.8	8.7	7.4	6.5	7.9	15.7	10.3	10.7	14.6	6.5	40.6	36.1	9.1	9.2	18.7	21.9	10.5	10.4	15.9	5.6	13.5	16.4	12.4	9.4	7.9	19.5	13.6	7.2	9.3	11.7	23.5	6.5	7.0	12.4	14.1	9.6	13.2	9.8	7.2	30.6	10.0	17.3	9.2	9.6	8.9	21.3	34.1	15.1	10.5	13.1	10.3	19.4	24.6	8.6	12.9	10.9	6.1	9.1	8.2	15.5	20.5	19.3	22.0	17.7	7.5	12.1	14.2	26.9	8.0	29.8	9.0	10.2	10.2	21.4	12.1	11.0	6.8	20.5	12.4	10.6	36.6	8.6	11.4	6.4	18.9	13.3	9.9	9.9	16.2	12.2	9.8	10.3	10.3	9.8	8.4	8.9	20.8	10.7	82.5	30.5	41.6	22.0	14.0	30.6	37.5	27.3	15.7	39.3	30.8	24.9	25.8	3.2	34.9	102.1	46.7	70.0	25.2	31.9	27.6	17.3	16.3	22.9	1.6	114.8	20.3	26.5	3.6	31.4	25.2	25.3	17.2	74.0	23.6	44.1	98.2	20.8	48.5	23.5	12.9	27.8	30.9	17.2	34.0	23.7	34.5	50.5	60.6
NT5C3B	"cN-IIIB, MGC20781, NT5C3L"	ENSG00000141698	"5'-nucleotidase, cytosolic IIIB"	Q969T7	17	41825181-41836263	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030786, HPA057095"	Approved					NA	NA					"HPA030786: AB_10602716, HPA057095: AB_2683333"	"unprognostic (3.90e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (3.40e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.07e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.80e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.42e-2)"	10.0	12.4	15.9	8.3	26.2	3.2	18.3	22.8	31.2	11.6	15.6	8.4	10.1	4.4	14.1	21.3	13.9	12.6	11.5	11.4	15.0	14.9	19.2	19.4	11.0	7.9	12.9	16.4	15.5	19.6	21.1	13.7	11.5	13.2	12.6	13.8	12.6	15.9	20.1	7.8	8.6	8.1	22.1	6.7	7.7	12.0	24.8	9.8	1.4	37.8	5.6	10.7	13.3	9.7	5.3	5.2	2.5	5.6	1.0	5.9	4.1	8.6	13.0	22.2	29.2	20.4	17.3	3.1	8.7	25.4	27.8	27.8	10.6	5.1	13.0	4.5	17.8	17.4	8.4	22.0	12.3	45.2	6.4	8.7	7.9	13.5	11.2	13.6	0.1	3.3	12.2	11.8	23.5	19.2	20.9	16.1	10.4	7.3	8.1	19.6	5.1	12.6	3.0	5.9	17.2	1.9	10.8	29.6	12.0	12.1	9.4	13.6	7.0	13.1	47.0	4.6	28.9	12.7	4.7	11.0	8.6	6.7	14.3	17.9	1.6	6.6	6.3	11.2	0.2	10.5	1.5	5.6	0.5	3.8	1.0	5.8	4.7	5.9	5.1	5.2	5.3	5.4	4.5	2.5	1.0	0.7	2.7	0.8	4.1	15.9	26.2	22.8	31.2	15.0	14.9	12.9	16.4	13.2	9.8	8.9	15.0	15.7	49.4	16.1	30.4	11.2	7.6	14.7	7.9	27.9	17.7	35.2	86.2	47.9	69.9	21.5	2.5	0.0	36.0	48.9	37.1	35.6	11.5	19.7	11.9	109.7	37.8	19.0	7.9	92.8	30.0	17.0	33.7	5.4	12.5	29.9	37.1	12.9	28.7	45.0	27.3	38.8	52.0	135.0	29.1	15.1	26.1	13.8	14.0	38.3
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
NT5M	"dNT-2, dNT2, mdN"	ENSG00000205309	"5',3'-nucleotidase, mitochondrial"	Q9NPB1	17	17303335-17347663	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 14.9;Erythroid cells: 23.3;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 10.1;U-266/70: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043777	Uncertain					NA	NA					"HPA043777: AB_10962842"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.42e-5)"	"unprognostic (4.28e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	2.6	1.8	7.2	2.0	7.4	9.4	2.1	8.8	11.8	3.3	2.8	3.7	3.1	2.1	2.8	1.9	2.7	3.0	1.9	6.6	5.8	5.3	3.3	5.5	1.7	1.7	5.5	3.9	3.8	1.9	2.9	5.0	1.5	5.7	3.3	1.4	3.5	2.7	2.7	27.1	2.1	2.2	2.0	4.1	1.7	1.3	7.0	2.0	4.2	1.7	2.4	1.6	2.6	1.7	0.2	0.6	3.6	0.0	0.0	1.5	3.1	0.4	0.9	0.4	3.5	2.2	2.4	1.6	0.7	0.2	0.3	0.5	0.0	0.2	4.0	2.1	0.0	0.7	0.0	0.2	0.1	0.0	3.4	2.2	2.6	0.0	0.3	2.1	0.7	5.2	1.7	1.8	0.3	1.4	0.7	0.1	10.1	2.2	0.0	0.0	1.0	3.3	2.9	2.2	1.1	3.1	2.5	0.3	7.1	1.2	0.0	4.4	6.8	1.2	0.2	3.1	2.7	1.2	1.0	0.0	1.1	1.3	0.3	0.9	11.1	1.4	0.6	0.6	0.5	2.8	0.0	0.0	3.6	0.1	0.0	1.4	0.0	0.1	1.5	0.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	3.1	7.2	7.4	8.8	11.8	5.8	5.3	5.5	3.9	5.7	2.0	0.0	0.3	0.0	1.7	1.4	5.8	7.2	0.0	0.0	1.2	8.7	2.0	0.5	14.9	0.2	0.8	0.8	0.0	23.3	0.5	0.9	1.0	1.2	0.0	1.0	1.2	15.9	1.2	0.6	0.3	3.6	0.6	0.5	0.0	0.0	0.6	3.5	0.0	0.0	1.1	1.7	1.5	0.0	0.9	0.9	4.1	0.4	0.5	0.9	0.2	0.4
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	18.2	12.6	22.4	5.0	16.0	3.1	14.3	2.5	23.4	6.5	11.0	7.9	5.9	16.7	4.7	11.7	7.1	12.6	9.8	20.9	15.4	13.5	16.7	11.2	12.6	9.4	16.1	14.8	4.0	26.0	4.7	27.6	4.8	11.2	10.5	4.6	14.7	16.7	9.9	28.7	6.2	13.8	3.1	13.2	6.3	12.7	8.9	7.8	3.1	17.9	9.2	5.7	4.9	4.7	5.8	15.1	1.7	27.3	6.1	5.8	8.9	8.2	11.3	1.0	4.4	1.3	1.6	18.1	2.3	3.1	3.8	5.5	8.0	8.8	0.6	11.6	1.2	8.5	10.4	0.5	6.3	0.3	4.3	8.3	1.8	4.9	5.5	9.7	2.2	22.3	2.3	8.0	0.9	0.7	1.6	7.5	4.1	2.8	1.4	1.3	24.0	0.2	0.0	5.9	19.5	15.8	4.3	10.4	4.8	4.1	23.8	15.7	2.3	4.1	0.1	9.6	1.9	8.9	10.7	17.6	6.3	2.8	4.5	2.3	0.7	0.4	1.0	9.3	2.5	2.3	1.7	18.5	0.5	5.8	17.4	3.6	5.8	4.6	3.8	15.1	4.0	4.5	5.2	0.6	6.1	27.3	7.3	2.5	8.9	22.4	16.0	2.5	23.4	15.4	13.5	16.1	14.8	11.2	7.8	11.9	22.0	13.7	80.0	34.6	11.8	47.7	35.7	34.8	5.7	33.2	17.7	39.7	149.2	84.7	2.5	43.4	95.9	0.0	26.5	19.7	19.5	39.7	39.1	21.8	112.1	33.4	35.8	22.7	24.1	8.2	10.6	28.5	43.9	36.9	61.8	28.1	58.1	126.7	3.5	138.7	12.3	0.0	9.5	10.0	28.9	16.7	31.9	15.2	80.1	65.1
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"K-562: 48.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA		2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Cell type enhanced"	"Detected in all"	5	"monocytes: 1878.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.9	210.9	42.5	50.3	51.2	57.5	35.1	88.9	207.7	142.9	144.6	59.3	101.0	62.4	90.0	166.4	106.4	119.5	134.4	181.0	112.0	109.5	63.5	38.2	106.1	49.1	35.6	49.5	82.5	52.2	84.3	110.0	45.2	185.5	84.1	32.1	9.5	50.1	225.2	50.9	18.5	21.3	52.6	125.8	80.5	55.0	136.1	118.9	189.6	105.5	44.2	48.3	116.0	71.6	90.9	74.7	50.2	36.1	65.4	162.8	89.0	159.0	161.3	64.4	90.9	55.0	200.4	82.0	159.4	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4	110.2	78.1	134.8	464.1	502.3	450.3	279.7	94.3	129.8	157.0	786.9	347.5	523.8	679.8	1147.1	307.8	224.6	361.4	70.0	528.2	1096.0	273.6	329.6	203.1	2.0	698.2	1005.9	270.8	71.2	307.3	1333.1	145.6	439.7	337.4	1878.3	130.3	624.4	887.7	231.5	252.1	165.5	510.0	122.9	245.6	32.6	84.3	340.0	481.5	163.0	247.6	730.1
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 276.6;Syncytiotrophoblasts: 540.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 82.7;U-937: 94.3"					"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		100000000	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.4	18.2	3.8	8.7	4.4	3.5	11.9	13.8	6.5	11.3	11.1	10.5	12.3	36.0	16.0	7.3	13.3	14.6	20.4	26.0	15.0	11.6	17.9	30.1	15.5	17.3	4.1	82.7	15.7	2.4	9.4	34.0	15.1	6.2	48.1	22.3	14.8	22.5	14.1	12.5	24.3	48.8	11.0	34.4	30.4	20.6	5.8	14.0	40.1	12.8	16.9	3.7	26.5	33.7	2.1	5.6	12.4	14.7	38.5	7.7	10.3	17.3	23.4	10.3	17.2	40.7	6.6	94.3	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5	0.0	26.3	18.6	51.4	75.2	4.8	3.1	28.1	8.1	17.0	78.5	13.7	276.6	33.2	38.4	1.0	60.2	56.3	93.5	44.5	26.6	19.4	21.8	56.6	23.1	63.4	15.9	44.5	19.6	22.4	0.0	0.3	46.2	28.7	1.0	31.7	70.2	85.7	56.1	0.7	91.5	17.0	0.0	33.8	0.2	0.6	55.8	540.4	19.3	34.8	70.5
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071231: AB_2686370"	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	7.6	7.3	7.1	15.0	11.6	5.8	10.7	19.0	10.6	9.2	8.3	5.9	12.0	7.9	9.6	9.7	14.4	8.4	7.5	7.7	9.4	8.3	8.8	12.0	7.7	16.5	8.8	11.6	9.7	11.0	17.5	11.6	8.1	8.7	9.1	9.1	6.2	11.0	14.2	7.9	10.7	9.8	8.9	7.9	10.6	8.8	6.0	11.0	20.0	10.3	15.1	11.7	11.1	10.0	1.7	1.9	1.7	1.8	2.0	3.0	0.6	7.7	6.1	8.5	15.7	6.2	5.8	7.0	4.9	3.9	4.9	5.8	7.4	5.0	9.4	4.2	5.7	9.3	9.8	9.4	7.7	7.6	2.0	6.7	6.7	7.8	6.2	6.6	11.6	8.2	5.7	9.3	4.8	11.0	7.2	4.8	5.5	14.1	3.4	6.1	13.9	2.8	10.5	13.4	2.7	6.3	4.6	13.8	6.9	5.8	10.2	8.7	14.4	7.0	11.7	10.3	11.4	7.1	13.7	4.0	5.9	9.4	6.7	8.1	10.5	8.3	8.4	5.9	8.5	7.6	0.0	0.9	1.7	2.4	1.8	3.0	1.7	1.8	1.7	1.5	1.3	2.2	1.8	0.1	2.0	0.4	1.9	1.2	0.6	7.1	11.6	19.0	10.6	9.4	8.3	8.8	11.6	8.7	11.0	0.0	5.1	5.4	3.1	3.8	7.7	11.5	5.1	4.0	6.8	0.0	9.8	2.2	1.7	5.3	0.8	4.3	4.9	23.3	5.1	1.8	4.2	4.6	5.7	4.0	3.1	20.6	4.7	9.2	7.9	1.0	7.5	2.5	3.3	1.8	5.2	5.0	5.2	3.6	8.1	3.7	7.4	0.0	5.2	4.1	3.3	6.0	1.6	6.9	5.6	3.5
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridylate synthase domain containing 4"	Q96CM3	11	126202094-126211692	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	7.5	6.8	5.1	7.7	7.8	6.0	7.8	8.2	9.6	6.3	6.0	4.8	7.6	6.4	7.0	6.8	7.8	7.2	5.2	13.2	5.1	4.9	6.3	10.2	5.0	7.7	6.5	8.1	10.1	16.1	5.7	5.1	4.5	7.2	6.9	6.9	5.2	9.5	8.2	72.0	8.9	5.9	8.3	4.8	7.6	9.3	7.0	7.1	6.2	7.7	18.2	9.3	6.2	12.0	9.8	11.0	1.0	8.5	8.4	15.2	8.7	6.6	6.7	8.0	9.6	12.6	16.5	5.7	7.5	10.5	8.2	7.3	20.5	13.2	15.7	7.4	6.7	11.4	11.7	18.3	11.5	8.7	13.1	10.1	36.6	7.1	19.2	8.3	19.2	8.4	15.1	17.4	8.9	11.2	12.3	16.4	12.9	22.8	11.6	9.6	6.5	12.0	22.2	8.8	22.7	11.8	14.1	12.2	14.5	12.5	9.7	13.9	9.5	9.6	14.3	7.0	8.7	21.4	10.2	9.9	9.2	6.4	6.9	8.8	4.9	5.2	13.5	4.2	21.9	9.4	1.0	8.5	0.8	10.8	7.7	14.0	9.8	13.3	10.3	11.0	9.5	15.2	12.2	0.7	8.4	8.3	4.7	12.2	8.7	5.1	7.8	8.2	9.6	5.1	4.9	6.5	8.1	7.2	7.1	3.0	6.7	16.7	17.9	24.5	8.9	30.7	12.7	8.1	5.7	7.0	7.9	11.7	8.3	10.7	1.1	11.3	9.7	0.0	16.9	13.7	10.1	10.5	5.7	11.1	11.8	11.1	14.9	8.6	10.2	1.4	8.9	8.5	10.1	21.6	9.3	4.5	13.0	7.0	8.1	11.8	7.6	6.5	10.8	7.7	15.4	21.0	11.1	15.9	15.7	13.3
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138876	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	Cytosol		NA	Yes		13000	Cytosol		"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	13.9	25.3	8.0	15.2	12.2	18.5	14.4	18.0	12.6	15.7	15.9	11.1	11.5	11.9	13.0	9.8	25.4	10.7	8.7	11.9	7.9	9.0	9.2	13.1	11.0	20.2	9.0	10.3	13.6	10.7	24.2	11.2	22.7	18.4	14.0	18.9	12.0	15.4	10.7	28.3	26.8	12.5	17.5	10.7	12.4	13.8	10.5	9.1	78.6	9.8	28.0	27.1	17.5	18.5	5.6	4.3	3.3	8.3	5.7	24.3	6.0	46.1	25.1	41.1	23.9	6.3	12.6	16.0	42.5	21.1	48.4	50.0	22.5	35.1	50.0	10.3	21.2	21.0	37.1	38.1	30.6	57.3	24.5	40.4	25.4	37.6	17.5	2.5	43.4	18.6	5.9	8.3	26.5	19.1	10.6	23.2	30.2	33.1	23.6	40.3	20.9	51.1	9.4	26.0	32.1	25.5	41.4	32.1	17.8	13.3	13.1	35.2	19.3	37.4	22.6	6.8	17.3	22.3	15.2	13.2	45.5	23.8	45.1	31.2	15.5	21.4	54.6	25.3	29.1	28.2	3.3	2.5	2.6	7.7	6.5	13.3	5.6	14.2	10.7	4.3	3.5	11.3	9.2	0.0	5.7	8.3	2.7	24.3	6.0	8.0	12.2	18.0	12.6	7.9	9.0	9.0	10.3	18.4	9.1	17.9	11.8	16.4	16.8	29.8	14.7	30.7	17.8	17.4	21.6	17.4	5.9	33.4	6.6	22.3	59.0	10.8	9.7	70.0	19.4	48.6	21.4	12.0	6.9	14.8	24.3	17.5	17.3	11.6	8.6	43.8	12.0	10.6	10.1	9.0	17.5	21.8	14.0	11.8	15.6	6.3	20.0	12.9	21.5	60.8	31.3	25.3	33.2	15.8	24.7	13.6
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Cell type enhanced"	"Detected in many"	19	"Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"	"Low cell line specificity"	"Detected in many"											HPA056994	Enhanced		Supported	Cytosol		Yes	Yes			Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.5	17.9	25.4	17.4	2.2	4.1	25.1	48.3	24.0	34.5	37.6	29.9	14.1	27.1	6.7	15.1	35.0	14.5	41.0	24.9	42.3	60.8	15.8	52.3	17.2	26.3	0.1	38.7	25.1	1.5	0.5	42.2	3.6	5.7	27.9	21.0	21.9	80.5	42.9	22.3	42.7	20.8	20.5	30.4	21.0	32.2	55.4	18.6	17.0	22.5	25.1	20.7	39.7	28.2	4.9	11.0	15.2	6.9	9.7	26.5	38.5	19.8	67.7	52.3	41.0	55.4	18.8	32.9	38.0	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0	3.0	1.0	2.2	1.0	9.3	0.0	1.2	2.5	5.3	1.2	0.0	0.0	5.4	1.7	0.5	3.0	0.3	2.6	93.5	0.0	192.1	3.6	1.1	5.7	1.7	40.1	0.0	0.0	5.5	5.9	5.7	0.3	3.5	0.0	0.0	7.9	0.0	0.5	0.0	0.4	1.6	0.0	0.0	0.3	5.2	44.5	1.4	40.7	7.2	13.0	2.0
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102239118	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.8	18.6	11.7	11.5	11.4	4.3	9.3	8.5	13.5	9.5	10.1	9.8	9.5	10.2	8.2	10.8	8.0	9.7	8.2	11.3	17.5	12.8	17.5	15.1	15.8	12.6	14.9	10.6	9.7	9.5	34.7	24.8	11.6	23.1	11.2	11.1	7.7	9.7	10.9	34.6	7.4	7.6	8.2	26.1	10.6	7.1	6.6	9.4	6.3	37.1	8.1	13.1	10.7	7.0	7.4	6.2	18.3	8.4	3.0	3.3	2.8	5.6	10.0	11.9	7.0	16.8	16.2	9.4	13.0	15.8	7.0	8.2	3.5	4.5	35.8	12.3	14.3	7.1	2.1	5.7	13.2	9.9	5.8	6.2	9.0	4.2	7.5	13.6	2.7	19.2	20.5	24.9	7.7	11.8	16.7	19.6	6.2	6.6	5.5	22.4	5.5	4.7	5.2	6.6	6.1	7.4	3.0	4.8	7.2	16.3	6.4	3.0	5.9	6.8	3.6	7.7	31.0	9.7	6.2	14.9	10.9	21.1	7.5	3.5	5.8	5.3	32.6	16.0	4.2	11.5	10.0	5.1	5.3	2.2	4.5	3.3	5.6	2.0	2.8	6.2	7.4	2.3	2.5	18.3	3.0	8.4	1.8	1.4	2.8	11.7	11.4	8.5	13.5	17.5	12.8	14.9	10.6	23.1	9.4	53.6	24.0	7.2	8.1	17.2	13.1	17.9	20.4	38.8	25.0	38.4	13.7	11.2	21.6	6.2	1.6	16.4	6.4	0.0	7.0	4.9	10.4	10.8	10.5	20.3	11.1	9.5	28.3	18.4	21.8	1.1	13.3	17.8	16.9	7.2	10.3	23.6	5.5	7.0	13.8	18.1	14.7	6.5	10.8	8.2	10.0	16.2	4.0	12.8	11.7	5.4
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174075-78187233	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0"	"Cell type enhanced"	"Detected in many"	14	"Extravillous trophoblasts: 178.8;Hofbauer cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB004683	Enhanced					NA	Yes					"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.87e-4)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	5.3	2.0	2.1	21.4	4.5	32.8	4.8	1.1	1.9	3.7	11.4	2.2	1.9	8.5	2.4	4.8	18.9	2.2	7.0	4.3	1.6	0.7	7.9	6.2	9.3	15.7	3.1	1.6	2.1	3.6	0.1	1.3	8.6	2.1	2.3	7.9	0.5	4.6	2.0	2.0	6.2	8.5	4.4	1.7	9.0	9.4	3.6	1.6	41.8	1.3	33.0	20.5	3.1	5.8	4.0	2.1	1.1	1.2	6.2	21.2	3.5	65.8	54.7	10.9	13.8	1.0	4.3	7.1	32.7	17.2	48.7	67.6	48.3	27.8	21.4	11.5	19.6	20.3	30.0	9.9	29.2	25.2	7.4	36.5	37.8	19.6	31.6	0.3	16.0	24.4	2.1	1.0	25.4	3.5	3.4	19.8	7.5	23.2	47.5	18.6	49.1	8.0	9.0	5.6	38.5	38.1	21.7	44.2	47.8	12.9	21.4	4.9	14.5	25.1	68.9	9.2	10.0	46.5	21.5	9.1	47.9	47.0	34.1	42.0	20.0	10.4	27.5	23.5	10.8	21.5	0.0	0.7	0.0	1.1	1.2	0.5	4.0	5.3	2.7	2.1	1.2	0.3	1.4	1.1	6.2	1.0	0.7	21.2	3.5	2.1	4.5	1.1	1.9	1.6	0.7	3.1	1.6	2.1	1.6	0.0	2.4	8.2	6.8	25.2	0.0	0.6	2.5	4.0	7.9	12.2	0.0	46.0	6.6	6.3	2.6	3.2	3.9	46.7	9.8	178.8	7.2	3.3	0.0	8.6	55.5	0.0	5.2	9.8	10.8	4.2	0.6	11.3	3.3	8.2	12.4	0.0	11.2	8.6	0.7	14.7	0.0	0.0	2.2	1.1	18.4	9.8	42.7	7.2	25.1	12.3
TK2	SCA31	ENSG00000166548	"Thymidine kinase 2, mitochondrial"	O00142	16	66508003-66552544	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041162	Uncertain					NA	NA					"HPA041162: AB_10961178"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.18e-6)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.05e-2)"	34.0	25.4	18.5	9.0	18.9	6.2	25.5	13.1	22.4	19.8	10.9	17.2	18.5	9.5	15.2	29.0	11.0	17.4	18.3	15.2	19.2	15.5	20.9	27.8	16.5	11.5	18.2	18.5	23.7	21.6	50.2	18.0	12.9	27.9	14.9	11.5	13.7	18.1	18.8	20.8	10.0	10.5	17.0	28.2	17.4	12.0	29.4	15.5	6.5	23.4	9.0	8.7	15.5	18.6	1.4	12.6	10.3	15.6	4.4	4.3	3.3	4.7	9.3	5.0	5.2	27.7	22.8	0.3	8.1	9.8	6.5	7.6	2.7	10.4	0.1	9.0	25.2	8.2	4.1	2.5	6.7	4.2	3.1	2.3	0.8	5.9	5.2	19.8	1.3	3.5	16.9	6.4	7.5	10.4	26.7	9.7	6.2	2.7	10.9	15.3	1.6	2.5	6.2	2.5	2.1	5.5	2.7	9.0	10.7	20.0	3.9	1.9	3.2	24.4	2.4	10.5	2.6	3.7	6.7	10.2	12.6	6.5	10.1	2.9	12.3	5.2	5.5	15.1	2.4	7.4	4.7	15.6	10.3	4.3	13.3	3.3	0.9	2.9	3.0	12.6	1.4	1.4	2.3	8.2	4.4	9.8	5.2	2.8	3.3	18.5	18.9	13.1	22.4	19.2	15.5	18.2	18.5	27.9	15.5	20.8	9.4	2.2	4.9	5.0	17.1	5.5	22.9	9.4	6.8	21.0	21.6	7.1	8.3	12.3	17.6	10.9	7.9	0.0	19.4	4.5	8.5	4.3	25.3	42.3	19.3	20.6	9.2	29.4	48.2	27.3	21.6	17.8	10.1	6.4	5.1	17.5	22.8	3.5	18.0	31.5	20.3	0.0	4.7	49.3	10.3	3.3	2.4	6.5	6.8	3.3
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Cell type enriched"	"Detected in all"	10	"monocytes: 27271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Cell line enhanced"	"Detected in all"		"OE19: 265.0"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		25000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	45.9	63.1	17.1	18.8	43.2	56.3	25.2	55.9	52.2	39.0	29.7	40.9	55.4	40.9	24.0	51.6	85.4	103.8	24.3	74.5	38.3	60.7	54.1	20.5	59.2	70.8	49.4	50.9	62.7	39.9	49.1	57.0	43.2	36.3	34.2	26.1	34.5	39.4	53.3	37.2	42.3	76.4	36.4	265.0	77.0	17.8	58.0	47.6	49.8	32.6	37.2	13.3	60.3	49.0	37.9	34.4	47.0	35.2	41.0	40.2	26.0	75.4	69.2	20.0	56.4	34.8	58.3	44.4	55.8	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0	363.3	237.5	189.1	832.3	1158.8	34.8	96.1	504.4	436.3	374.2	249.5	19.6	560.0	824.0	1017.1	20.9	327.5	1162.8	233.6	1150.3	840.4	409.8	774.5	261.1	685.2	516.6	27.0	534.8	206.2	278.9	11.1	373.3	793.2	723.7	27271.2	934.3	40.9	1608.6	1292.8	268.3	2636.4	24.8	142.3	563.4	10.6	70.3	1303.3	391.5	213.2	1478.0	1356.2
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467036-36482030	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	22.1	69.9	33.4	24.7	33.2	23.5	41.9	23.2	51.1	23.0	25.9	20.8	24.5	36.9	19.8	22.7	28.7	26.9	27.6	60.1	28.0	28.6	33.4	51.7	27.9	35.5	30.3	31.7	35.0	51.1	30.8	17.3	19.6	30.4	21.6	26.2	24.6	25.0	27.5	72.3	21.0	28.1	26.3	35.6	25.2	26.7	19.1	21.2	16.2	29.2	37.3	23.0	23.0	19.8	31.7	51.3	14.4	43.3	32.0	30.0	45.1	14.4	19.7	21.6	36.9	32.5	35.4	24.8	19.9	31.1	33.5	38.1	23.9	15.3	36.5	18.4	30.9	14.6	22.0	41.4	34.0	19.5	25.0	36.0	41.6	26.9	35.2	27.4	50.0	39.8	47.3	27.0	28.0	21.9	28.1	30.3	20.4	43.5	30.2	29.9	21.3	22.7	38.8	17.5	44.7	26.0	20.8	22.8	25.3	33.9	23.5	30.1	30.4	20.0	43.9	35.7	18.0	30.9	48.5	23.8	37.4	29.2	20.5	19.4	24.6	17.4	35.5	33.7	31.2	21.2	5.2	40.8	7.1	25.7	43.3	26.8	31.7	25.6	27.0	51.3	29.0	30.0	27.9	14.4	32.0	35.2	39.1	24.8	45.1	33.4	33.2	23.2	51.1	28.0	28.6	30.3	31.7	30.4	21.2	56.6	49.0	65.6	79.6	74.1	107.9	96.0	79.0	53.5	53.4	66.3	37.3	190.8	257.0	78.1	16.6	64.6	168.3	0.0	93.1	240.7	63.4	47.2	68.1	102.9	150.9	109.7	86.0	69.3	73.9	27.8	52.3	81.0	74.2	82.0	111.4	131.5	75.1	94.7	47.7	140.1	54.1	19.4	58.7	50.5	41.1	78.4	173.2	69.9	151.3	64.8
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350305	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 272.3;Urothelial cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 144.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm		NA	NA		5900000	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	19.1	79.2	14.1	15.6	16.9	22.6	18.5	11.1	13.7	13.0	21.8	9.7	19.7	23.5	23.5	14.7	16.7	19.0	23.2	32.4	11.0	11.7	25.3	19.6	29.3	18.1	12.0	10.9	16.4	7.9	10.5	16.2	30.8	16.4	25.3	19.1	18.1	10.6	26.5	30.0	5.7	17.0	99.6	10.9	14.9	24.2	14.8	8.9	15.6	16.5	16.9	13.2	73.2	72.0	8.1	14.2	37.6	16.2	8.3	10.2	8.7	22.2	103.7	12.1	11.3	58.1	32.6	42.0	41.4	26.2	18.7	19.4	10.9	33.2	16.7	19.3	144.9	70.2	7.8	23.8	15.9	22.2	8.1	10.3	14.1	81.4	46.1	93.3	21.9	15.4	18.5	16.4	41.4	13.2	57.6	64.1	23.0	19.3	7.9	28.0	10.7	22.4	10.0	11.6	44.8	106.9	22.3	8.4	14.5	21.8	12.3	18.8	11.4	33.5	53.0	33.0	23.9	12.5	13.0	85.6	9.2	19.1	20.6	33.9	8.7	17.0	25.1	19.3	12.2	54.4	33.0	10.6	24.7	9.1	14.0	10.2	8.1	8.4	9.0	14.2	5.2	7.6	6.6	37.6	8.3	16.2	9.2	7.1	8.7	14.1	16.9	11.1	11.2	11.0	11.7	12.0	10.9	16.4	8.9	59.6	55.0	27.6	272.3	92.4	28.0	55.7	38.2	104.4	96.7	15.7	21.6	22.9	34.9	73.1	34.3	40.9	44.4	23.3	68.7	28.0	34.6	217.3	50.9	45.7	36.8	27.0	19.7	50.3	37.2	13.4	63.0	64.0	18.6	55.9	17.9	23.3	183.4	20.3	27.6	28.5	19.7	0.0	58.8	11.6	28.8	63.7	42.9	23.5	24.1	489.6
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA		410000	"Vesicles, Mitochondria, Cytosol"		"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.4	13.3	1.2	5.2	2.4	3.4	3.0	6.2	7.3	11.2	8.3	12.4	6.7	3.6	15.1	6.5	11.6	11.4	6.2	8.5	4.3	6.8	15.3	6.0	10.6	7.3	4.6	6.7	2.9	3.3	6.5	5.7	4.9	4.6	31.8	0.7	33.2	6.1	8.7	15.6	2.3	10.0	6.1	15.9	9.5	3.4	29.6	3.3	6.8	7.0	6.6	5.8	10.7	13.9	7.1	2.1	11.4	9.1	17.7	8.2	49.4	6.8	13.0	6.1	4.4	2.2	7.9	5.1	10.3	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8	14.9	27.1	5.2	19.2	3.8	20.0	13.6	17.8	13.4	10.3	19.2	9.8	51.6	49.7	18.7	21.0	11.3	13.5	0.0	27.8	19.6	12.5	19.5	1.1	47.4	23.3	9.5	1.2	10.4	20.5	14.1	14.4	12.1	5.0	25.2	12.1	19.0	19.9	14.0	8.5	44.0	9.5	6.5	9.1	8.6	12.8	4.5	35.1	11.7	14.7	12.7
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530056	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Cell type enriched"	"Detected in many"	5	"monocytes: 2738.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;HHSteC: 40.2;Karpas-707: 38.8;U-266/70: 18.6"	"Low region specificity"	"Detected in some"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		16000000	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	25.2	7.9	2.8	41.6	8.4	12.1	19.0	1.5	4.4	10.7	10.7	3.8	2.3	10.4	4.4	15.7	22.0	13.7	9.6	15.0	7.0	2.6	18.6	38.1	28.8	57.8	6.5	0.4	7.5	5.8	1.7	3.9	11.5	9.1	7.9	4.9	5.4	16.5	3.8	10.0	8.8	13.9	7.3	15.2	43.9	12.4	3.0	5.0	13.3	12.5	25.5	28.8	12.4	9.4	0.9	12.2	18.2	23.0	0.8	0.9	2.6	6.7	0.8	0.0	0.1	1.0	1.3	0.6	1.2	0.1	2.4	5.4	0.0	16.2	0.5	0.8	2.7	0.8	5.9	0.2	0.3	0.0	2.8	1.4	0.3	1.1	0.4	40.2	0.1	7.7	2.5	2.4	3.2	0.0	0.1	0.0	0.0	0.2	38.8	0.2	0.1	0.0	1.0	0.0	0.9	2.1	0.2	0.0	7.8	0.0	0.0	0.0	1.4	6.2	8.5	0.6	0.0	0.7	4.9	1.5	0.0	0.6	0.1	0.2	18.6	3.8	0.4	0.2	0.1	0.2	2.5	23.0	18.2	0.3	22.4	0.2	0.8	0.3	0.2	12.2	0.9	0.2	0.1	6.7	0.8	15.9	1.1	0.9	2.6	2.8	8.4	1.5	4.4	7.0	2.6	6.5	0.4	9.1	5.0	11.9	35.6	80.8	45.0	52.0	2.9	2.0	40.8	21.4	19.4	31.4	3.9	11.5	24.9	326.6	1.8	45.0	161.9	0.0	563.3	281.5	67.3	63.5	54.1	80.8	472.8	0.0	16.1	38.1	417.7	8.6	4.6	429.6	108.0	2738.6	29.6	2.0	289.0	94.7	1.8	76.1	5.4	25.8	44.2	1.4	8.3	49.4	28.0	34.5	27.7	63.3
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657604-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 75.5"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 109.0;Spermatocytes: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 13.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 6.7;olfactory region: 8.8"	"CAB002784, HPA074922"	Enhanced					NA	Yes					"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	3.0	2.6	4.6	15.5	5.8	34.9	2.8	1.2	6.3	3.4	10.1	10.2	1.5	4.8	2.5	3.6	12.3	2.4	4.6	2.0	5.8	2.9	4.8	5.1	4.2	15.4	3.4	4.5	2.0	3.1	1.1	1.3	14.3	3.4	3.0	12.9	1.1	3.4	0.8	0.7	3.6	6.9	5.5	4.6	8.9	4.2	21.5	5.3	75.5	1.7	10.9	19.3	4.8	4.3	1.2	1.8	1.0	0.1	6.8	13.8	2.5	13.9	21.5	44.9	21.7	5.0	8.4	22.8	32.9	19.7	35.6	42.7	18.1	11.2	21.7	12.9	17.7	20.2	6.3	31.3	12.4	30.8	20.4	34.8	36.8	20.2	31.1	1.1	75.6	40.4	7.4	2.9	22.4	7.0	6.8	29.7	46.2	29.5	34.9	44.8	16.0	91.0	41.9	16.2	17.0	16.1	60.2	40.4	26.1	13.3	12.4	15.3	24.9	27.8	12.9	8.3	29.1	8.8	34.5	11.7	41.2	81.4	37.7	64.2	43.3	53.3	49.6	10.9	32.7	47.0	0.0	0.0	1.0	1.1	0.1	0.0	1.2	2.9	2.2	1.8	0.0	0.0	0.7	0.6	6.8	0.1	0.3	13.8	2.5	4.6	5.8	1.2	6.3	5.8	2.9	3.4	4.5	3.4	5.3	0.0	2.9	3.0	11.2	12.8	0.4	2.1	5.1	0.0	7.9	0.0	0.0	36.1	1.7	2.4	18.3	1.5	8.4	23.3	0.7	109.0	7.2	4.0	6.9	1.7	57.9	0.0	1.2	6.2	15.9	22.3	5.8	9.2	10.1	6.4	13.0	42.9	1.4	3.5	3.5	19.4	1.9	12.9	4.1	197.1	30.9	6.4	22.5	7.5	39.0	3.5
UCK1	"FLJ12255, URK1"	ENSG00000130717	"Uridine-cytidine kinase 1"	Q9HA47	9	131523801-131531268	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050969, HPA070526"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA050969: AB_2681294, HPA070526: "	"unprognostic (2.20e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (5.11e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	13.2	15.9	21.7	13.7	22.5	13.7	15.6	29.9	23.2	15.0	15.6	17.3	20.8	11.4	12.2	19.3	14.5	17.6	16.5	21.0	19.6	18.4	18.3	26.7	12.7	12.9	20.4	19.1	21.3	24.0	17.6	14.4	16.4	14.8	14.9	9.2	17.6	24.1	18.3	30.0	12.0	12.2	14.8	19.9	12.1	13.4	15.7	15.6	12.5	18.5	10.8	11.5	13.6	9.4	7.9	6.6	9.4	7.8	6.8	13.5	6.1	7.0	15.7	18.2	23.3	12.9	9.2	15.5	11.5	17.0	20.0	15.2	15.6	6.5	7.7	7.0	13.8	15.6	13.8	16.9	14.7	8.6	14.1	15.7	7.2	23.6	9.8	18.5	11.8	10.7	10.3	13.9	16.1	11.7	12.1	12.2	19.2	9.0	5.9	14.6	28.2	16.0	6.0	21.5	13.9	15.7	15.4	28.1	12.9	12.8	6.7	24.6	15.5	16.6	12.7	17.9	8.7	24.8	7.0	8.9	22.2	11.3	13.7	11.2	12.2	15.6	9.8	11.0	8.3	15.4	2.3	6.2	9.4	8.5	7.8	11.3	7.9	10.1	7.6	5.7	7.9	13.5	6.8	4.1	6.8	2.7	6.6	12.3	6.1	21.7	22.5	29.9	23.2	19.6	18.4	20.4	19.1	14.8	15.6	14.9	5.3	14.9	10.3	12.7	17.5	12.9	7.6	0.0	3.4	14.0	7.9	26.0	24.9	19.6	15.1	13.4	17.0	0.0	22.9	12.0	15.5	11.2	2.3	19.4	22.3	25.4	11.6	11.1	11.1	20.2	16.4	8.2	15.1	27.1	11.8	17.7	15.6	11.6	18.7	23.7	10.2	19.4	18.9	29.3	29.4	10.9	21.5	9.6	11.8	7.1
UCK2	UMPK	ENSG00000143179	"Uridine-cytidine kinase 2"	Q9BZX2	1	165827531-165911618	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.8"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057128			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057128: AB_2683346"	"unprognostic (5.37e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-3)"	"prognostic unfavorable (9.22e-8)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.12e-13)"	"unprognostic (2.49e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.83e-1)"	12.5	7.1	6.5	11.1	8.6	11.6	17.5	16.9	9.6	9.3	18.4	8.9	11.0	15.3	10.1	15.3	20.5	8.8	9.0	9.6	6.4	6.6	6.6	14.6	11.1	10.3	10.5	6.6	7.5	17.6	7.9	9.4	65.8	11.2	8.1	19.9	5.0	16.1	9.9	20.9	15.0	24.8	10.0	8.2	7.7	13.2	7.2	7.9	13.1	6.4	12.4	12.3	9.0	11.1	3.4	14.7	0.8	5.6	3.4	3.9	2.0	25.2	26.3	14.2	12.7	7.3	12.2	23.1	27.9	20.6	29.8	34.0	24.9	27.8	12.5	19.9	17.3	12.1	20.8	26.6	32.8	26.7	22.9	22.4	14.5	22.6	25.6	18.2	28.3	11.1	11.5	16.9	56.2	35.0	7.2	19.6	24.1	38.3	18.0	26.7	18.3	25.1	18.2	38.9	35.2	25.5	11.5	15.6	42.5	13.8	16.5	21.4	25.3	19.9	39.4	19.3	28.3	24.3	27.0	20.4	16.7	23.3	18.9	29.5	24.2	36.0	46.3	14.4	18.8	12.7	0.8	5.6	0.1	1.8	3.7	3.9	3.4	1.7	2.4	14.7	3.4	0.0	1.4	0.2	3.4	3.2	14.0	2.2	2.0	6.5	8.6	16.9	9.6	6.4	6.6	10.5	6.6	11.2	7.9	0.0	1.4	3.0	24.7	20.4	4.3	4.1	12.7	1.4	4.5	8.7	0.0	1.2	6.6	15.0	94.9	15.3	22.2	0.0	19.1	46.9	11.0	10.1	0.0	4.9	11.9	0.0	6.4	4.9	3.5	31.3	6.1	7.1	10.1	17.2	13.7	4.0	38.8	14.4	3.2	5.8	4.2	0.0	9.0	5.2	11.5	26.0	22.1	4.8	18.3	20.9
UCKL1	"FLJ20517, URKL1"	ENSG00000198276	"Uridine-cytidine kinase 1 like 1"	Q9NWZ5	20	63939829-63956415	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 130.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004722, HPA004769"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA004722: AB_1080455, HPA004769: AB_1080453"	"unprognostic (1.03e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.87e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.26e-3)"	17.4	18.1	16.5	16.0	18.3	21.1	19.8	50.4	20.7	18.5	21.9	21.6	17.3	32.0	18.0	17.7	19.7	17.9	12.0	21.0	17.1	9.4	21.3	20.6	15.6	18.3	20.3	11.5	31.7	22.6	14.1	22.1	17.5	15.7	19.4	9.1	31.0	28.9	24.4	52.3	27.9	29.8	18.1	11.8	26.7	20.1	11.5	19.7	16.7	24.1	33.1	20.1	16.2	21.2	22.2	8.9	6.3	14.0	5.3	14.8	7.9	11.5	12.3	10.6	14.1	7.8	6.7	17.1	9.3	6.4	19.3	9.7	29.3	9.0	11.7	15.7	6.0	13.2	19.0	8.2	12.8	3.8	4.9	13.8	8.9	24.6	42.8	8.6	15.1	17.0	9.3	11.5	7.7	6.4	7.7	8.9	11.6	12.5	12.5	6.0	14.9	17.7	26.4	7.8	9.2	28.8	18.1	8.0	20.1	7.9	16.8	25.2	14.7	13.4	13.2	14.2	5.5	13.8	13.7	9.8	20.5	7.7	13.3	12.0	13.1	7.0	5.4	10.5	10.8	7.7	4.2	7.7	6.3	13.2	12.9	14.8	22.2	12.8	11.2	8.9	12.7	7.5	9.0	1.2	5.3	14.0	5.1	13.5	7.9	16.5	18.3	50.4	20.7	17.1	9.4	20.3	11.5	15.7	19.7	23.8	8.8	20.2	17.9	16.8	27.5	18.2	22.9	8.1	11.4	8.7	78.5	27.3	19.9	17.0	1.9	16.5	26.3	0.0	9.6	20.5	15.0	11.6	12.7	10.5	16.0	19.1	20.6	10.4	9.1	2.2	16.4	13.4	10.1	22.6	20.8	17.1	16.9	23.0	19.4	12.3	130.6	25.8	18.7	10.7	14.0	16.7	27.9	9.6	21.7	17.1
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730366-124749273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	8.4	12.2	4.9	6.8	6.8	4.8	8.0	9.3	7.6	5.9	9.1	8.5	5.2	8.4	6.8	6.7	13.2	8.2	6.6	3.6	4.0	3.9	9.6	20.7	5.2	10.1	7.3	3.6	8.9	19.0	9.5	9.3	11.6	4.7	6.4	7.1	6.4	8.9	4.0	10.9	9.5	8.5	5.5	5.9	9.8	8.3	6.8	6.2	10.6	7.4	12.0	9.3	7.8	6.4	16.6	13.1	4.6	9.8	10.2	13.0	7.9	1.4	4.4	5.0	2.1	3.0	3.5	5.3	7.5	2.3	3.2	2.7	3.8	2.0	3.8	8.3	2.9	6.6	8.4	7.1	2.5	5.0	4.4	4.1	7.8	2.8	2.6	2.6	8.2	5.9	3.9	2.3	2.0	3.9	1.9	1.4	7.7	3.5	1.8	2.3	3.4	10.0	1.6	11.1	3.9	2.8	6.6	6.0	3.2	2.5	2.5	4.0	2.6	11.3	4.0	4.2	3.8	4.0	3.0	14.4	2.5	5.0	6.9	3.0	7.5	10.2	10.5	2.8	3.4	2.5	4.5	9.0	4.6	12.5	9.8	12.1	13.7	8.9	11.3	13.1	16.6	13.0	10.4	0.6	10.2	8.0	9.7	10.3	7.9	4.9	6.8	9.3	5.7	4.0	3.9	7.3	3.6	4.7	6.2	6.0	7.8	5.2	15.9	14.1	8.0	5.7	12.7	22.7	10.3	8.7	3.9	56.7	24.9	23.5	3.1	13.4	10.4	0.0	26.6	27.5	9.3	9.3	11.5	28.8	19.3	4.8	9.2	8.0	5.4	3.9	12.7	9.6	3.3	21.6	9.4	10.1	19.5	7.0	13.1	19.5	7.7	12.9	9.9	19.7	30.7	16.7	91.3	12.8	15.8	15.5
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 85.7"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 119.4;monocytes: 36.9;Proximal tubular cells: 58.6"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"basophil: 11.4;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 11.4"	"Group enriched"	"Detected in some"	5	"CACO-2: 11.2;NB-4: 4.6;THP-1: 6.1;U-937: 6.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		790000			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.1	0.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.6	0.1	0.5	0.1	0.0	0.1	0.5	0.1	0.0	13.5	85.7	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	11.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	11.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.3	1.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.1	0.4	0.3	0.1	0.0	0.2	1.1	1.3	0.4	0.0	0.0	0.0	6.1	0.5	0.1	0.1	0.0	0.0	1.2	0.1	1.3	1.4	6.9	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.3	0.0	1.2	0.6	3.0	1.8	0.0	0.0	0.0	1.8	9.8	0.1	10.0	0.1	0.8	2.3	0.0	0.0	0.3	0.1	1.0	1.0	0.0	119.4	0.1	0.0	2.4	4.9	3.7	0.9	0.3	0.0	0.0	36.9	0.0	0.3	0.0	0.0	0.0	58.6	2.0	0.0	2.1	3.4	6.4	1.0	0.2	0.0	0.0	0.7
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108733	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 206.2;Macrophages: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.7	8.4	2.8	12.6	4.2	17.6	7.1	5.7	3.8	10.3	8.0	1.7	2.1	7.5	2.8	4.2	37.7	3.3	8.5	7.0	2.3	3.3	12.4	9.1	18.3	17.4	5.8	1.4	2.9	5.8	2.4	5.0	28.9	5.5	3.0	7.6	2.9	7.5	2.1	5.1	2.0	9.7	5.2	3.9	13.9	2.5	1.8	4.8	1.2	6.2	34.0	19.4	7.9	19.6	0.6	8.2	15.7	22.0	5.7	19.7	16.0	6.5	7.9	0.8	1.6	2.7	1.2	8.1	3.2	4.5	4.1	5.1	3.3	3.2	0.0	1.2	2.6	26.4	4.6	1.5	13.1	2.7	1.3	1.4	0.2	1.9	1.3	2.4	0.2	0.5	1.6	6.4	1.9	103.9	1.9	2.7	0.2	0.4	3.9	2.2	0.7	0.0	1.1	3.1	1.1	6.9	0.0	1.7	1.7	9.5	3.4	0.7	0.7	3.3	0.9	24.1	8.9	0.8	0.2	3.8	9.7	8.3	2.6	8.2	7.5	10.0	1.1	9.8	1.0	23.6	15.7	22.0	15.1	19.7	16.7	12.5	0.2	12.6	13.5	8.2	0.6	13.0	12.0	9.1	5.7	15.9	0.7	11.2	16.0	2.8	4.2	5.7	3.8	2.3	3.3	5.8	1.4	5.5	4.8	17.9	64.1	14.6	17.3	41.6	27.8	10.4	22.9	8.1	13.6	10.4	31.4	6.0	59.7	36.9	0.6	58.5	53.1	0.0	35.8	206.2	39.5	10.1	24.4	15.1	111.9	15.9	12.5	78.5	137.0	1.5	4.9	205.8	82.7	43.3	11.6	13.5	73.7	52.6	2.1	15.4	28.8	6.5	33.0	0.0	3.0	26.1	65.8	46.7	13.3	29.6
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 11.6;Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.9	0.0	0.7	0.8	0.9	0.0	0.0	0.0	0.1	1.1	0.6	1.2	1.4	0.3	0.0	0.3	0.6	0.6	0.4	0.4	0.5	0.0	0.4	0.8	0.1	0.0	0.2	0.2	0.0	0.0	1.2	0.1	0.4	0.3	1.2	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
UPRT	"DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3"	ENSG00000094841	"Uracil phosphoribosyltransferase homolog"	Q96BW1	X	75274085-75304600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000805	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000805: AB_1080482"	"unprognostic (3.12e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.53e-3)"	8.8	15.3	14.6	7.9	15.8	14.9	10.7	20.3	18.7	11.5	9.9	10.8	10.8	14.2	10.0	12.5	13.0	10.2	8.4	12.0	13.1	17.7	15.5	11.3	10.0	10.7	14.9	9.6	8.7	14.1	18.7	19.5	7.6	13.2	12.8	11.0	9.1	13.1	8.6	13.3	7.4	10.5	14.0	10.9	11.0	13.9	3.0	12.4	10.6	13.9	6.5	11.9	9.1	7.9	8.3	11.1	8.9	16.4	14.7	13.3	7.4	7.8	5.6	6.2	5.8	6.7	7.3	5.9	5.5	6.6	6.0	6.7	4.9	5.3	11.0	4.8	5.7	10.6	3.4	14.3	5.0	9.7	10.0	5.7	6.9	5.9	6.2	6.5	13.5	14.4	5.5	3.5	8.3	4.3	9.5	10.4	9.1	8.0	11.1	15.6	3.3	15.3	8.3	12.6	5.8	9.2	7.2	16.4	5.3	15.3	4.6	0.4	6.5	7.8	8.1	7.6	11.5	3.6	8.6	8.7	7.6	4.6	13.9	4.7	7.6	24.6	10.7	8.1	14.9	4.8	5.1	7.4	8.9	8.3	10.7	9.5	8.3	8.3	8.5	11.1	7.2	10.5	9.3	1.3	14.7	16.4	5.0	13.3	7.4	14.6	15.8	20.3	18.7	13.1	17.7	14.9	9.6	13.2	12.4	6.0	5.3	8.2	7.9	5.6	6.2	5.2	0.0	1.4	6.8	8.7	0.0	6.4	23.2	7.6	1.4	7.1	5.2	0.0	5.3	11.5	5.6	6.9	24.2	5.8	10.5	9.5	5.8	14.1	10.8	0.5	4.0	11.0	13.5	4.6	5.9	8.8	4.7	2.9	3.2	13.4	6.3	6.5	7.2	0.4	1.7	5.3	10.2	8.9	6.0	5.6
